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Farmed Atlantic salmon (Salmo salar L.) produced across 4 continents contributes globally 
to food security and regionally to social and economic development. Salmon is the biggest 
selling seafood product in the UK and particularly for Scotland, its economical relevance is 
highlighted by the job opportunities and prosperity the farming activity brings to the country’s 
most remote coastal areas and rural communities. 
 
A major constrain to profitability and expansion of a sustainable production is the impact of 
disease, with viral conditions among the most serious.  
Historically, Pancreas disease (PD) and Sleeping disease (SD) were recognised 
independently affecting Atlantic salmon and rainbow trout (Oncorhynchus mykiss), 
respectively. Both were found to be induced by closely related isolates of the same virus 
species, Salmon Pancreas Disease Virus (SPDV).  The aetiological agent belongs to the 
genus Alphavirus within the family Togaviridae and infection can lead to clinical disease with 
characteristic acinar pancreatic necrosis and a range of myopathies (skeletal and heart 
muscle). Mortality is not a necessary outcome and it is frequently not significant. However, 
severely affected fish stop eating and therefore have reduced growth rate and fish can also 
present visible lesions at the fillet level leading to downgrading at time of slaughter.  
 
The current thesis developed at Marine Scotland Science (MSS), the Scottish National 
Reference Laboratory, was policy driven to produce work which would contribute with 
knowledge gaps identified by the industry and research communities.  
 
The focus of the thesis was to improve in vivo and develop in vitro infection models, aiming 
to assist with studies on the host pathogen interaction, primarily of SPDV but also other 





The in vivo work resulted in the first successful co-habitation challenge model applied by 
MSS, working in sea water with Atlantic salmon post smolts, the developmental stage 
predominantly affected by the disease. The in vitro work accounted for the more innovative 
part of this thesis. An ex vivo cardiac tissue culture originated from Atlantic salmon embryos 
were explored as a species-specific model for studies of viral host -pathogen interactions. 
While in vitro fish based models had been previously developed and extensively applied in 
biomedical research, paradoxically they have been much less explored as disease model for 
fish health issues. The work involved an adaptation and refinement to produce salmon 
cardiac primary cultures (SCPCs). To test permissiveness to viral infections, SCPCs were 
successfully challenged with SPDV as well as other cardiotropic viral agents. The kinetics of 
viral infection and some aspects of the immune response could also be studied. SCPCs 
were maintained under laboratory conditions with minimal support for a period up to 6 
months. Moreover, their potential to examine genotype-based differences linked to their 
embryo of origin was explored, and the model was also used to gain insights on the 
ultrastructural morphology of SPDV replication cycle by transmission electron microscopy 
examination. 
  
With SPDV and other virus associated myocarditis affecting Atlantic salmon aquaculture, the 







Salmon Pancreas Disease Virus (SPDV) is the only viral species of the genus Alphavirus, 
family Togaviridae, affecting fish. 
 
SPDV induces two conditions historically recognised independently as Pancreas disease 
(PD) and Sleeping disease (SD), affecting Atlantic salmon (Salmo salar L) and rainbow trout 
(Oncorhynchus mykiss), respectively. Infection by SPDV can lead to clinical disease with 
characteristic acinar pancreatic necrosis and a range of myopathies of the skeletal and heart 
muscle. Mortality is not a necessary outcome of the disease and usually is not significant. 
However, affected fish stop eating and therefore present a reduced growth rate and the 
disease can also leave visible lesions at the fillet level that lead to downgrading at slaughter. 
SPDV can affect in the fresh and sea water environments, but a higher and most relevant 
impact reported in the latter. Historically, PD has posed a significant challenge to the Atlantic 
salmon farming industry in the UK, as well as in other salmon producing countries. 
 
This thesis was developed and conducted at Marine Scotland Science (MSS), the Scottish 
National Reference Laboratory, with the aim to contribute to knowledge gaps identified by 
the industry and research communities. The focus was on development and improvement of 
in vivo and in vitro infection models to assist with host pathogen interaction studies. 
 
In vivo work was to establish an experimental challenge model to induce SPDV infection in a 
more natural way than by intra-peritoneal (IP) injection. The first step involved selection of an 
infective SPDV isolate through a comparative IP challenge study. An infective isolate was 
then used to establish a co-habitation challenge model in “post smolts”, the sea-water stage 
predominantly affected by PD. Additionally, during this experiment assessment of viral tissue 






In vitro work accounted for the more innovative part of this thesis with the development, 
optimization and application of an ex vivo cardiac primary culture originated from Atlantic 
salmon embryos. While fish origin aggregates of self-contracting cardiomyocytes had been 
previously isolated and suggested as a robust tool on human biomedical research and 
pharmacological and toxicology testing, paradoxically very little has been done to explore the 
approach of ex vivo primary cultures as a disease model with the specific goal for health 
issues affecting fish. The work involved an adaptation and refinement to produce salmon 
cardiac primary cultures (SCPCs). Once this was achieved, SCPCs could be kept under 
laboratory conditions with minimal maintenance for periods up to 6 months. Following this 
work, SCPCs were successfully challenged with different SPDV isolates as well as another 
cardiotropic viral agent (Infectious Salmon Anaemia, ISA). The kinetics of SPDV and ISA 
viral infection and one element of the immune response (i.e. expression of mx gene) were 
studied. As part of this study, the comparative response of SCPCs of diverse genetic 
backgrounds (i.e. IPN resistant vs. IPN sensitive) was also assessed. Differences were 
observed, which highlights potential usefulness of SCPCs to examine genotype-based 
differences in response to viral disease. Finally, SCPCs were used to examine the SPDV 
infection cycle ultrastructure by transmission electron microscopy (TEM). This work resulted 
in novel insights on the replication cycle of SPDV, drawing from the extensive literature in 
mammalian alphavirus work. 
 
With SPDV and other virus associated myocarditis severely affecting Atlantic salmon 
aquaculture at present, I believe that the SCPCs model represents the most relevant 
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CHAPTER 1: INTRODUCTION 
 
Aquaculture and food security  
 
With a general decline in the world’s marine fisheries since the late 1990’s, farmed fish and 
shellfish production has been called to play a bigger role in the supply of an increasing 
demand for fish and other aquatic food species. World fish consumption per capita reached 
over 20kg a year in 2014, a record influenced by the combined effect of management 
improvement on some stock fisheries but significantly, by the vigorous growth and 
contribution of aquaculture which now provides 50% of all fish for human consumption [1]. 
Moreover, the actual share of wild fish stocks exploited within biologically sustainable levels 
adds a further concern, as it has declined from 90% in the 1970s, to 68.6 % by 2013 [1] 
resulting in over 30% of the stocks effectively being overfished. In this context, aquaculture 
has become the world’s fastest-growing agricultural business [2] (Fig. 1).  
The production of salmonids by aquaculture has markedly increased in the past 30 years at 
the time their capture has declined steadily (Fig 2) and while not the largest by biomass 
within world fish global production, salmonids are a highly valued commodity due their 
important input to the regional economy of several countries. This is reflected by the strong 




Fig 1: Current status of the contribution from capture and aquaculture to the global world totals of 






Fig 2: Capture versus production of Atlantic salmon. Source: FAO Species Fact Sheets 
http://www.fao.org/fishery/species/2929/en 
 
In Scotland, the aquaculture industry is dominated by the production of Atlantic salmon 
(Salmo salar, Linnaeus, 1758). This historically iconic fish is a pride for a country that is 
home to some of the finest salmon rivers in the world (see http://www.salmonatlas.com/; 
http://www.salmonfishingscotland.com/). Farming of Atlantic salmon has also its origin in the 
UK, with the early work in the 19th century focusing on the freshwater production of juvenile 
fish to re-stock rivers aiming to enhance the returns. In Scotland Atlantic salmon is highly 
valued in terms of its ecological role as central to aquatic biodiversity, water quality and 
environmental changes indicator and a key stone species for recreational fisheries [3].  
 
Years later, salmon production in Scotland pioneered the aquaculture industry with 50 
tonnes harvested in 1973, rising to 28,000 tonnes 15 years later and reaching 152,000 
tonnes by 2013 [4]. Farmed Atlantic salmon is currently the biggest-selling seafood in the 
UK, making a substantial contribution to the Scottish economy estimated at £670m in 2015 
[5]. Its economical relevance is compounded by the job opportunities and prosperity 
aquaculture has brought to many of the country’s most remote coastal areas and rural 
communities [6]. 
 
Salmon is currently produced in countries across 4 continents and is estimated to provide 
directly and indirectly over 120,000 jobs and up to $10 billion US dollars globally [4]. The 
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main producers are Norway, Chile, Scotland and Canada, followed by Ireland, USA, New 
Zealand, Australia (Tasmania), Denmark (Faroe Islands) and Iceland (Fig 3).  
 
 
Fig 3: Total Atlantic salmon production by country from 1990 to 2010. ROW: rest of the world. Source: 
FAO Fishstat. 
 
In order to support the growth of salmon aquaculture, reliable research data is essential for 
the implementation of evidence-based policies to balance the environmental sustainability 




Atlantic salmon belongs to the family Salmonidae within the order Salmoniformes. They are 
diadromous fish (migratory between fresh and sea water), specifically anadromous, therefore 
adults live in the sea and migrate to fresh waters to breed [8]. 
 
The life cycle of Atlantic salmon starts with spawning in fresh water. Salmon will migrate up 
river to different locations depending of the time they enter the fresh water. The mature 
females build nests in the gravel where her eggs will be deposited and fertilised by the 
sperm of one or several males. The eggs are then covered with layers of gravel forming the 
“redd” where incubation takes place. The location for spawning along the river varies and will 
occur first in the higher reaches of the rivers and, progressively, at lower altitudes later on 
the season. The average winter temperatures are higher at lower altitudes and 
consequently, and in spite of the later spawning, hatching takes place first at low altitudes 
and progressively at higher altitude locations later [9]. This suggests that spawners match 
their spawning time with the winter temperature characteristics of their location and as a 
result, the timing of fry emergence tends to match the advent in late spring of local stream 
conditions that are favourable for their survival [9]. 
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The young fish, known as “alevin” or “sac fry”, retain a yolk sac from where they feed for a 
few weeks while remaining in the protected environment of the redd. With the sac fully 
absorbed and approximately 3cm in length, they emerge from the gravel as “fry” to start 
independent feeding. Once more, temperature determines not only the rate of development 
and the hatching time, but also the date at which the yolk-sac is fully reabsorbed and 
therefore the beginning of external feeding. The fry grows up to become a “parr”, identifiable 
by the development of conspicuous flank marks. Parr continue feeding and growing for one 
or more years until they are ready for “smoltification”. This is a complex adaptive process 
involving coordinated changes in the morphology, biochemistry, physiology and behaviour, 
that prepares parr for downstream migration from the river into the sea [10]. As fish become 
“smolts”, significant changes are observed in their appearance, turning silvery and slender, 
losing positive rheotaxis (facing the water current) and abandoning the bottom dwelling 
behaviour to start schooling downstream [11]. The duration of this process depends on water 
temperature and food availability, and usually occurs at 2-3 years of age in Scotland. 
Interestingly, if a smolt fails to enter the marine environment within a certain period they will 
undergo a relatively quick “de-smoltification” process until the following season [11,12]. 
Overall, the most common river age (time spent in this environment) for salmon is 2–4 years, 
and most common sea age at first spawning is 1–3 years [13].  
 
Life at sea is challenging with growth and survival depending on factors including sea 
surface temperature, competition for food, predation, fishing, pollution and infection by 
parasites and other disease agents. The marine phase is effectively a serious challenge that 
drastically reduces the numbers of fish that will reach adulthood and return to the rivers to 
start the cycle again [14].  
 
During oceanic life, adult salmon grow rapidly on a diet of crustaceans and small fish. Adult 
salmon undertake extensive migrations which, depending on where they start their journey, 
can take them to the coasts of Norway, the Faroe Islands or south-western Greenland [15]. 
By the time they become sexually mature, they will have spent one or more years at sea. At 
this point, salmon migrate back to the river where they originated re-entering at different 
times the year, but mainly between April and November. This depends mainly on whether 
they return after one year (“grilse” with average weights of 2-3kg and summer entry), or have 
been several years at sea (“Multi-Sea-Winter fish” or “salmon”, which returns earlier in the 
spring). The latter have been longer at the feeding grounds and are much larger animals, 
reaching up to 15kg [12,16]. Once in fresh water, adults do not feed and live on accumulated 
reserves until spawning in the autumn. Unlike their Pacific relatives (Oncorhynchus spp.), 
Atlantic salmon is iteroparous, meaning a proportion can survive reproduction and go back to 
the ocean to feed the following spring, returning again to spawn the following year  [8]. The 





Fig 4: Atlantic salmon life cycle. Sourced at “Salmon in the classroom”. 
(http://www.snh.org.uk/Salmonintheclassroom/salmon_lifecycle.shtmlX) 
 
In summary, wild Atlantic salmon is a highly valued biological and economic resource which 
faces many challenges and uncertainties, particularly those that compromise survival during 
their oceanic life. Therefore, the species is the focus of considerable efforts, commitment 
and determination by the international community to support their conservation and the 
preservation of their habitats [14,17]. Additionally, as mentioned above Atlantic salmon is 
one of the main aquaculture species worldwide. 
 
 
Farming of Atlantic salmon  
 
The production of farmed Atlantic salmon aims to simulate the natural lifecycle up to the 
adult stage. In this respect, farmed fish are hatched, raised and harvested under controlled 
intensive rearing systems. Production still requires both fresh and sea water phases. The 
former is performed in land-based hatcheries from egg incubation to pre-smolt stage, and 
the latter in sea water enclosures starting from transfer of the pre-smolts to sea until harvest 
between 18 and 22 months later [18].  The majority of the industry transfers smolts to cages 
in open water systems for on-growing to harvest weight. In recent years, some companies in 
Scotland, Norway and Chile are investing into Recirculation Aquaculture Systems (RAS), 
enabling land-based production of smolts. The rationale behind the RAS includes the 
reduction in the mortality typically associated with smolt transfer to sea which can account 
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for up to 20% of the stock [19]. Farmed smolts show high vulnerability when they first 
encounter the marine environment and the right timing for transfer to full sea water is crucial. 
Transfer is frequently accompanied by increased disease susceptibility, mortality and a 
period of reduced feed intake and growth rates [20]. Therefore, the use of RAS expects to 
achieve stronger and larger smolts before they are put into sea water and a shorter sea 
growing stage.  
 
The salmon industry is tightly controlled, and companies normally have in place strict health 
management, bio-security and emergencies contingency plans. In-house veterinary support, 
regular disinfection procedures and disease mitigation programs are the norm. Many also 
voluntarily comply with government managed monitoring and surveillance schemes for the 
prevention of specific diseases and coordinate synchronised zone/area management 
programs [21,22].  
 
Several factors challenge the sustainable growth of the salmon farming industry including 
economic, environmental, nutritional and health issues. In this thesis I focus on a specific fish 
health related matter and therefore, this overview will also focus on fish health factors.  
 
Industry challenges: health management   
  
Unfortunately, one of the major constraints to the successful expansion of a sustainable 
salmon farming industry is still the management of health issues and disease control [23,24]. 
This hampers development due to significant economic implications, but it also poses a 
serious animal welfare concern [25,26].  
 
Health challenges can arise and be influenced by different factors, which may be intrinsic or 




The inherent characteristics of fish (species, sex, reproductive stage, genome, etc) are the 
most obvious and relevant intrinsic factors. In the selection of a new species for production, 
one of the initial most relevant factors is the capacity to adapt to the farming condition where 
selective pressures comes into play, favouring the developing of those organisms that are 
better suited for it. This process is referred to as “domestication” [27]. Additionally, some 
commercial production systems involve the use of monosex and sterile stocks, benefiting 
from the optimization of production strategies and reproduction containment. In some 
species, one sex growths faster, matures later or is of higher commercial value. For 
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example, male salmonids normally mature a year earlier than the females, and therefore the 
combination of monosex and sterility serves the dual purpose of preventing the growth loss 
associated to the development of reproductive structures and avoids the risk of potential 
interbreeding of escapes with wild populations [28]. However, production of sterile triploid 
Atlantic salmon has also health issues to overcome, such as a higher incidence of cataract 
and heart and skeletal deformities [29,30]. 
On the other hand improving the genomic background through selective breeding for 
enhanced performance has been for years the focus of both the producers and researchers 
alike [31]. Part of the work presented here is focused on the effect of genomic background 
on disease; hence the following expanded review of this subject. 
 
Compared to that of terrestrial livestock, the selective breeding of Atlantic salmon is relatively 
new [32]. However, major and accelerated advances have taken place in the past ~20 years 
and today specialised professional breeding companies offer embryonated ova with 
desirable trait/traits that are tailored to the challenges encountered by the industry. The 
selection of candidate brood stocks is performed by different approaches, usually assisted 
by identification of suitable individuals by detection of genetic markers associated with the 
selected trait [33].  
 
From the breeder’s perspective, desirable traits include improved robustness, fillet colour 
and growth, delayed sexual maturation, production of sterile fish and importantly, resistance 
to disease [34]. Many characteristics are usually affected by a large number of genes that 
individually have a small effect on the trait, but the combined effect explains a large part of 
genetic variation. One of the genetic markers used is the QTL (quantitative trait locus) a 
genetic locus, the alleles of which affect a given variation. Generally, quantitative traits (a 
measurable phenotypic variation) are multifactorial and influenced by several polymorphic 
genes and environmental conditions. Therefore one or many QTLs can influence a trait or a 
phenotype [35] . The identification of a QTL (and occasionally its functional analysis) allows 
to link two types of information, the phenotypic data (the measure of the trait) with the 
genotypic data (one QTL or a combination of QTLs), in order to explain the genetic basis of 
variation [36].  
 
A quite rare and successful case has been the discovery of the QTL associated with 
resistance against a viral disease known as Infectious Pancreatic Necrosis (IPN). IPN 
resistance was found not only to be heritable, but that the trait was almost entirely explained 
by the variations in a single QTL located on linkage group 21 (LG 21) with significance at the 
genome-wide level [32,37]. This soon resulted in breeding companies implementing this QTL 
in marker-assisted selection (MAS) and the production of ova leading to fish with a high 
resistance for IPN [37]. Similarly, markers associated with a major QTL affecting resistance 
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to Pancreas disease (PD) induced by Salmon pancreas disease virus (SPDV) and focus of 
this thesis have been recently reported to being incorporated into selective breeding 
programs to improve PD resistance [38].  
Recently, another major step forward has been the development of a powerful exploratory 
tool that enables the efficient capture of a high numbers of QTLs associated with a given 
trait: SNP chips. This technology involves the use of a high-density map made of Single 
Nucleotide Polymorphisms (SNP) markers. The use of SNP chips enables the correlation 
between the predisposition to disease and the genotype at hundreds of thousands of loci per 
fish [39]. This procedure is called Genomic Selection (GS), and it overcomes the challenge 
of the traditional method of identification of QTL analyses based on low number of markers, 
where only a limited proportion of the total genetic variance is captured by a single marker. 
 
Selection of broodstock based on genetic markers has effectively started a new era within 
the field of salmon breeding and currently, ova selected for several traits including resistance 




Extrinsic factors influencing cultured fish health arise from a wider spectrum of variables, 
including nutritional, environmental, husbandry, and the presence/absence of specific 
pathological agents. These are briefly outlined below. 
 
 Nutritional 
As with any livestock, nutrition has strong effects on fish stress tolerance and general 
performance. An adequate supply of balanced nutrients is paramount for normal growth, as 
well as for maintenance of an efficient immune system. This encompasses the mechanisms 
to fight against potential pathogens, linking nutrition with health status directly [41]. There are 
also pathological conditions that are the direct result of nutritional deficiency/imbalance such 
as hepatic lipoidosis, steatitis, enteritis or skeletal deformities associated to vitamin 
deficiencies, for example [42]. 
 
 Environmental 
Among the environment factors, water quality plays a most critical role and can significantly 
affect fish health. Variation of key water quality parameters outside acceptable ranges for the 
species can lead to stress, distress, impaired health and mortality [43]. Water quality is 
usually more stable in the marine environment, and is more critical during the fresh water 
phase, especially in recirculation (closed) systems. Relevant parameters include 
temperature, dissolved oxygen, pH, alkalinity, salinity, water hardness and dissolved organic 
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matter. All of these need to be monitored and maintained in accordance to the species 
requirements and the culture conditions. For example, a most common problem in farmed 
fish is associated with oxygen, where both hypoxia and hyperoxia can result in vascular and 
metabolic disorders that lead to acidosis and death [42]. 
 
 Husbandry 
Husbandry can have a major influence on the fish and their welfare. Practices such as 
grading, transport, strategies for predator’s control, vaccination, fallowing periods (or lack 
thereof) are some examples. Another major example is associated to inappropriate stocking 
densities, which can lead to acute welfare infringements or to a chronic reduction in welfare 
status, as well as facilitating horizontal transmission of disease [44].  
 
 Diseases 
Many of the factors above described have been optimized and minimized during the 
development of aquaculture practices but the presence of bacterial, viral and parasitic 
diseases still remains at the top of the production challenges, generating the largest 
economic losses in salmon farming. An unfortunate and spectacular example for the salmon 
industry has been a viral disease, infectious salmon anaemia (ISA). Outbreaks, in Norway 
(1984), Scotland (1998), and Chile between 2007 and 2009, resulting in unprecedented 
economic losses and severe social impact [45]. 
 
Among diseases, those of parasitic and viral aetiology are the major concerns. Parasitism by 
sea lice (Lepeophtheirus salmonis) is the main problem for the Atlantic salmon industry, 
causing economic and welfare losses, leading to environmental impact, and having a 
detrimental effect on the public perception of the industry [46,47]. Viruses remain important 
pathogenic threats to the aquaculture industry in general, and to farmed salmonid species in 
particular [48]. Several viral conditions affecting Atlantic salmon include infectious pancreatic 
necrosis (IPN), infectious salmon anaemia (ISA), infectious haemorrhagic septicaemia (IHN), 
viral haemorrhagic septicaemia (VHS), heart and skeletal muscle inflammation (HSMI), 
cardiomyopathy syndrome (CMS) and pancreas disease (PD/SD). These diseases cause 
massive associated losses to the global salmonid aquaculture industry [48].  
 
With no efficient available treatment for piscine viral diseases, their control relies on either 
costly vaccination strategies, preventing the introduction of the causal agents or, once in the 
system, implementation of comprehensive management strategies. 
With few historical exceptions, preventing introduction is very challenging due the nature of 
the system of intensive farming itself. Once the pathogen has entered the farm, the 
aquaculture environment can facilitate disease, mostly due to the high concentrations of 
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available hosts. This leads to easier pathogen load amplification through horizontal 
transmission. Farmed fish can act as disease vectors for wild fish if they escape [49]. 
Additionally, specific infectious viral agents can survive outside the host for some days and 
even longer when adsorbed to other substances like clay, which extends the survival in the 
environment to weeks. This favours maintenance and spread of virus in the environment 
[50]. As a result, the impact of viral disease is not only to other hosts in the immediate 
vicinity, but further within the inter-connected water systems through current and tidal flows; 
common features in the coastal areas, lochs and fjords where most salmon farming sites are 
located [51]. 
 
Among viral conditions affecting farmed salmonid, Salmon Pancreas Disease Virus (SPDV), 
is responsible for the diseases known as Pancreas disease (PD) in Atlantic salmon, and 
Sleeping disease (SD) in rainbow trout (Oncorhynchus mykiss). SPDV has represented one 
of the most significant health issues faced by the farming industry for an extensive period of 
time [52], and is the focus of this thesis.  
Although SPDV is also widely referred to as Salmonid alphavirus (SAV), in this thesis SPDV 
will be preferred as the only currently approved name by the International Committee of 
Taxonomy of Viruses (ICTV, 2013). 
 
 
Alphavirus: the agent 
 
Alphavirus is one of the two genera within the family Togaviridae containing over 40 
members present worldwide in a wide range of invertebrate and vertebrate hosts [53,54]. 
The vast majority are arboviruses (transmitted by arthropod vectors), with their most 
common vector being mosquito species, although ticks, biting flies and lice can also be 
vectors for specific alphavirus species [55]. Vertebrate hosts include primates (humans and 
nonhuman), horses, pigs, rodents, birds, reptiles, amphibians and fish. 
 
Many Alphaviruses around the world are responsible for a number of diseases of major 
relevance for human and veterinary medicine. Examples of these are infections associated 
with arthritis, rashes, fever and encephalitis. Viral maintenance in the environment is largely 
based in transmission between vectors and vertebrate hosts [56]. This is coupled with 
replication efficacy in many members of the genus, and a broad range of susceptible hosts. 
These characteristics has made them useful vector tools, and some alphaviruses have been 
patented as viral vectors (Semliki Forest virus (SFV), Sindbis virus (SIN) and Venezuelan 
equine encephalitis virus (VEEV)) and used for applications such as vaccine construction 
and therapy for cancer and central nervous system diseases [57,58]. Finally, in what could 
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be considered quite an opposite application, Alphavirus are also of biological warfare 
importance, due to the capability for airborne transmission of some species [59,60]. 
 
Overall, due to their relevance as a disease agent for humans and domestic animals, the 
genus alphavirus has been extensively studied and is one of the best-characterized 




Alphaviruses are small, enveloped viruses with icosahedral spherical morphology, 65~70 nm 
in diameter, molecular mass of 5.2x106Da, density of 1.22g/cm3, and a single copy of 
positive stranded genomic RNA of approximately 11.5 kb in length. This RNA has a type 0 
cap (7-methylguanosine -m7G- cap structure) at the 5' end and a poly (A) tail at the 3' end 
[54,61]. The latter characteristic makes the alphavirus genome present itself to the host cell 
as a messenger RNA (mRNA) for immediate translation upon entry into the cytoplasm [56]. 
There are two open reading frames (ORFs) in alphavirus genomes, encoding four non-
structural proteins (nsP1-4) involved in replication and pathogenicity, and five structural 
proteins (C, E3, E2 6K and E1) composing the virion [56]. Untranslated regions (UTRs) at 
each side of the ORFs are located at the 5' and 3' ends of the genome and between the 
ORFs (the subgenomic 5' UTR) (Fig 5). Beyond the traditional areas of viral promoter 
function and translational regulation, the 5' and 3' UTRs in alphavirus have other important 
and diverse roles related to immune evasion, host cell tropism, and viral pathogenesis which 
are only recently coming to be known [61]. 
 
 
Fig. 5: schematic representation of the alphavirus genomic RNA. Open boxes =NS-ORF (non-structural 
protein ORF) or S-ORF (structural protein ORF), solid black lines=UTRs, P62= precursor of E3+E2), 5’ 
m7G= 7-methylguanosine cap structure (type 0 cap), A(n)3’= poly adenylated tail. (adapted from [62]. 
 
 
However, some key information on UTRs remains obscure, including the evolutionary forces 
that shape the genome heterogeneity among viral species and strains (or subtypes), which 
can vary greatly in length and sequence structure. For instance, SPDV, the first member of 
the group isolated from a fish, is the species with the shortest UTRs (5'-: 27 nucleotides; 3'-: 
87–130 nucleotides) within the genus, while the Semliki Forest (SF) complex is the most 
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divergent and contains the longest UTRs with the greatest diversity in length (5'-: 76–85 
nucleotides; 3'-: 227–713 nucleotides) [61]. 
 
The Alphavirus genomic RNA (R) is enclosed by 240 copies of capsid proteins C, arranged 
in a T4 symmetry (triangulation T=4) forming an icosahedral shaped nucleocapsid (NC) 
measuring 40nm (Fig 6). The NC is enveloped by a host acquired lipid bilayer membrane 
(M), in which 80 trimeric shaped spikes (S) are embedded (Fig 7). The spikes are formed by 
240 copies of each E glycoprotein that are also icosahedrally ordered forming a scaffold that 
surrounds the viral membrane [54,63,64]. Each spike is a heterotrimer consisting of two 




Fig 6: Schematic representation of an alphavirus virion demonstrating the spherical icosahedral shaped 
particle, with genomic RNA encased by the nucleocapsid and surrounded by an envelope conformed 
by host acquired lipid bilayer membrane embedded with (80) trimeric shaped spikes protruding from 
the surface.  
 
 
From the outside in, three distinct segments of each the spike can be identified; a projecting 
domain that extends from the surface budded into a three-lobed structure (S), a thin plate 
domain covering the bilayer membrane (the skirt, turquoise coloured in Fig 6-B), and a 
transmembrane domain that penetrates the lipid bilayer connecting the projecting portions of 





Fig 7: (A-D) Alphavirus structure based on Sindbis virus. A) Surface view down at the icosahedral 
twofold axis. Trimeric spikes are seen as protruding flowers in blue. Red arrows point to visible small 
portion of the lipid bilayer of the membrane underneath. B) cross-section of the virus showing the 
organization of the particle with the glycoproteins (blue), skirt region of the envelope (turquoise), the 
lipid bilayer (green) penetrated by the transmembrane helices of glycoproteins, the protease domain of 
the capsid protein (yellow), and protein–RNA region (orange). C) Radial section of the nucleocapsid 
core viewed down at the icosahedral twofold axis. D) Graphical representation of genomic RNA (R) 
and capsid proteins (C) conforming the nucleocapsid (NC), lipid bilayer membrane (M) and spikes (S). 
E) complete viral intra cytoplasmic particle as observed by TEM, scale bar 100nm (A-C adapted from 
[54], D from [63], and E from [66]. 
 
 
Alphavirus replication cycle 
 
Due a wide range of susceptible  hosts, the majority of Alphaviruses are capable of 
replicating in a range of vertebrate and invertebrate cell lines [67]. The alphavirus replication 
cycle has been thoroughly studied, mostly using reference viruses in mammalian or 
mosquito cell lines, respectively (SINV, SFV and Chikungunya virus -CHIKV-). These two 
approaches have shown to have different outcomes, normally with clear cytopathic effects in 
vertebrate cells, and with persistent infections with only partial cytopathic effects in mosquito 
cells [68–71]. 
 
The widely accepted current replication cycle model for how Alphavirus transfers its RNA 
into the cell starts with the virion binding to a cell receptor where the envelop E2 
glycoproteins are believed to be responsible for the attachment. This is followed by clathrin-
mediated endocytosis and internalisation into an endosomal compartment [72]. Within the 
endosome, the mildly acidic pH triggers the dissociation of the transmembrane glycoproteins 
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(E2/E1 heterodimer) and a structural rearrangement of the virion. The latter releases E1 from 
its regulation by E2, exposing the fusion peptide of E1 responsible for membrane fusion, 
which inserts into the endosomal membrane bringing the virus and the endosome 
membranes together, forming a fusion pore that allows the nucleocapsid (NC) to enter the 
cytoplasm where it undergoes disassembly, exposing the viral RNA for translation [54,73].  
 
For the purpose of this literature review, is important to note that although is well established 
that a protein receptor on the host membrane must be an entry requirement, an accurate 
identification of such receptor remains obscure  [74,75]. Moreover, with better purification 
protocols and improved methods of analysis, the mechanism has recently come under 
scrutiny and an alternative pathway of entry, without involvement of endocytosis, involving 
exposure to acid pH and/or membrane fusion has been suggested [75]. These authors 
propose a direct release of the virus genome into the cytoplasm by a pore complex made 
from viral and host proteins. The hypothesis is supported by alphavirus cell entry having 
been shown to be a leaky process that allows passage of ions and small molecules across 
compromised plasma membranes [73]. Although the authors do not deny the existence of 
the aforementioned mechanism of endosome formation and acidification, they suggest that 
these events take place later on and away from the process of entry, and may occur only 
under laboratory conditions [75]. 
 
Nevertheless, the subsequent steps are not a matter of controversy and once the viral RNA 
is released, replication occurs in the cytoplasm within vacuoles derived from endosome and 
lysosome membranes. The first proteins to translate from the full-length viral RNA are the 
non-structural proteins, allowing the assembly of viral replicase complexes at membranes. 
The synthesis of the minus strand RNA predominates early in the infection whilst the plus 
strand and subgenomic RNA synthesis occurs later in the infection [54]. The structural 
proteins are then translated from the subgenomic RNA as a single polyprotein (capsid (C)-
E3-E2-6K-E1). The virus assembly is a highly regulated process comprising multiple 
cleavage and oligomerization events. The capsid proteins (C) are autocatalytically cleaved 
off from the structural polyprotein and remain in the cytoplasm to encapsidate newly 
synthesized genomic RNA forming a new NC [76]. The resulting polyprotein (E3-E2-6K-E1) 
is subsequently translocated into the endoplasmic reticulum (ER) where it is processed by 
the host signalases yielding E3-E2 (known also as pE2), the precursor to E2:E3–E2), 6K and 
E1. The association as heterodimers between pE2 and E1 takes place in the ER. Each 
component is glycosylated and heterodimers eventually oligomerize to assemble into trimers 
of heterodimers, to form a spike (S). They are transported through the Golgi to the trans-
Golgi network where pE2 undergoes furin- like protease dependent maturation, releasing E3 
from E2 to the plasma membrane (PM) via the cell’s secretory pathway. The presence of E3 
within the heterotrimers provides resistance to the acidic environment preventing premature 
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activation. At the PM the trimers are arranged in an icosahedral array morphologically 
appearing as 80 flower-like spikes in the surface of mature virions [56]. When the 
translocated NC interacts with the endoplasmic domain of E2, the NC becomes enveloped 
by the E1-E2 icosahedral scaffold as it initiates the budding process [54,76,77], (Fig 8). 
 
 
Fig 8: Alphavirus replication cycle. Adapted from Kielian Lab 
https://sites.google.com/site/kielianlab/research 
 
Most of Alphavirus life cycle insights come from morphological and structural 
characterisations in vertebrate hosts, while the mechanisms of replication and assembly in 
the invertebrate hosts until very recently, remained relatively poorly understood. However, 
new research applying a variety of techniques including electron microscopy, live cell 
imaging and fluorescent dually labelled protein-tagged viruses, has provided strong evidence 
of fundamental mechanistic differences in the virus-host interaction between the insect 
vector and the mammalian hosts [71]. 
 
Based on this, a model was proposed for the spatial and temporal regulation of the 
alphavirus life cycle (Fig 9) in the mammalian host cell (Baby hamster kidney -BHK-15-) (A) 














Fig 9: Model suggested for the alphavirus life cycle and the virus-induced structures in mammalian (A) 
and insect (B) cells. After [71] based on infection by Sindbis virus (SINV). 
 
In essence, it has been shown that the replication and assembly machinery of alphaviruses 
is highly modified in mosquito cells, allowing continuous production of viruses at a reduced 
level (consistent with persistent infections). The non structural proteins and viral RNA in the 
replication complex (RCs) of mosquito cells were observed to have a distinct spacial 
organization in cytophatic vacuoles, compared to RCs in the mammalian cells. Specifically, 
through live imaging, ultrastructure (TEM) and inmunofluorescence, evidence was provided 
that the mechanism for RC formation in mosquito cells is based around vesicles containing 
glycoproteins, with a proposed novel mechanism for replication complex formation capable 
of producing internally released particles by budding of complete viral particles into them. 
These may eventually be secreted as individual virions out of the cell through the secretory 
pathway [71]. This contrasts with the RCs in mammalian cell lines which are characterized 
by the induction of bulb-shaped membrane invaginations (spherules) limiting membranes of 
large cytoplasmic vacuolar structures (CPV type I) where viral RNA synthesis occurs. CPV-I 
are the proposed site of viral RNA synthesis, in which nsPs accumulate at the cytoplasmic 
neck of the spherules and the newly synthesized RNA diffuses into the cytoplasm through 
the spherule pore (ad Forshauer et al 1988, Jose etl 2017). 
  
These different mechanisms may have relevance for SPDV (the focus of this thesis), where 
there is no identified arthropode vector and direct horizontal transmision between fish is 
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possible, and where some events of the virus life cycle and transmission have not been 
observed or remain unclear [78]. 
 
Salmon pancreas disease virus (SPDV)  
 
When a new member of the alphavirus group is described, as has been SPDV, it benefits 
from the extraordinary baseline of information due the prolific work performed worldwide on 
Alphaviruses in general and on the many different host organisms/cells.  
 
SPDV was the first member of the group with a fish species host and one of the few 
exceptions to an arthropod vector requirement [79–82]. It was found to be responsible for 
two major disease conditions in salmonids, known as Pancreas disease (PD) and Sleeping 
disease (SD) [52]. SPDV can live in fresh, brackish and marine water where the reservoirs 
are clinically diseased or covertly infected fish [83]. It primarily affects salmonids (Atlantic 
salmon Salmo salar, rainbow trout Onchorhyncus mykiss, and brown trout (Salmo trutta) 
[52,84,85]. SPDV has also been found in some non-salmonid marine species such as the 
common dab (Limanda limanda) without development of pathological changes [86–89]. The 
presence of SPDV in the common dab from regions not associated with salmon farming, 
supports a hypothesis that the dab represents a bone fide wild reservoir of the virus, 
independent of aquaculture activity [87]. Additionally, SPDV viral RNA has been detected by 
RT–PCR in sea lice (Lepeophtheirus salmonis) collected from Atlantic salmon 
simultaneously infected by the parasitic arthropod and SPDV. This led to the suggestion of 
sea lice as hypothetical vectors for the virus. However, there has been no proof of replication 
in the lice or certainty that the identification could have originated from non-lice tissues such 
as poorly digested blood, or remnants of host tissues. Therefore the role of the sea lice in 
SPDV infection transmission remains speculative [90,91]. 
 
There is limited published data regarding the life cycle of SPDV in the fish host. The limited 
published work include studies of the ultrastructural morphogenesis of SPDV in vitro (using 
Chinook salmon embryo -CHSE-214-,) and a thorough in vivo description of the 
pathogenesis by ultrastructure after experimental in vivo infection [78,92].  
 
SPDV subtypes and serology 
 
A phylogenetic analysis of the SPDV viral sequence (partial E2 and nsP3 genes) 
demonstrated that isolates recovered along a 18 years period from clinical cases,  rather 
than being homogenously distributed were grouped in clusters, and six subtypes were 
suggested [93] (note SAV 1-6 = SPDV 1-6). These subtypes were shown to correspond to 
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geographic areas [94] with some subtypes showing a more restricted distribution, like SAV 3 
(only recorded in Norway), SAV 5 (only in Scotland) or SAV 6 (infrequently present in 
Ireland). SAV 1 and SAV 4 are reported in both Scotland and Ireland and SAV 2 –the only 
strain present in fresh water- is reported in the UK and in continental Europe (Fig 10). A sea 
water strain of SAV 2 exists, and has been long known to exist in Scotland and has been 
more recently reported in Norway [94–96]. In general terms, infection by SPDV in fresh water 
is referred to as SD and normally affects rainbow trout, while in sea water is known as PD 
irrespective of whether it affects the most usual host Atlantic salmon, or rainbow trout reared 
in sea water.  
 
 
Fig 10: SPDV subtype distribution in Europe (source Jansen et al., 2017, Journal of Fish Diseases 
2017, 40, 141–155). 
 
Since the early descriptions of PD and SD and before the current subtype assignation, the 
virus causing these diseases were already recognised as different strains [97]. The cases 
affecting rainbow trout that were being reported in England and Scotland as well as in 
continental Europe were all considered to be caused by a SPDV subtype that is exclusive to 
fresh water. In light of the much wider information brought by both improved detection 
methods and increased surveillance in the last decade, the particular situation with SPDV 2 
became clearer. It is now understood that there are two distinct branches of SPDV 2, namely 
the original one reported in France in rainbow trout (i.e. the aetiology of SD), and another, 
genetically distinguishable, SPDV 2 strain causing disease in Atlantic salmon at the marine 
phase. Interestingly, the marine field isolate P42p which had been isolated in CHSE-214 
cells from farmed Atlantic salmon in Scotland [98] and historically had been considered as 
the Scottish type strain, was identified later as a marine SPDV 2 by sequence analysis 
21 
 
[82,93,94] . This confirms that marine SPDV 2 was present in Scotland from the initial PD 
descriptions. SPDV 2 is actually a very frequent, if not the most frequent, subtype in certain 
marine farming areas in Scotland, Shetland Islands and Orkney islands [94] (and internal 
MSS diagnostic records). Moreover, the marine SPDV 2 has been recently reported in the 
Norwegian industry [95], after years of reporting only a genetically homogenous and distinct 
type (recognised now as SPDV 3)  [90].  
 
Virulence and pathogenicity variations have been known for PD but since the assignation of 
subtypes, it has become apparent that this variation happens both between and within 
subtypes. Different isolates representing all 6 subtypes (F07-220 SPDV 1 from Ireland, F06-
290 SPDV 2 from Scotland, PD03-13 SPDV 3 from Norway, F04-44 SPDV 4 from Scotland, 
F07-192 SUPDV 5 from Scotland and F02-9 SPDV 6 from Ireland) were shown to induce 
different level of lesions, mortality or have a different pace of disease development  [99]. 
More recently, intra subtype difference in virulence was also confirmed [100]. 
Recently, the serological reactivity between strains of each of the six currently genetically 
defined subtypes was examined [101]. When these authors compared the homologous and 
heterologous virus neutralization titres on sera from field cases and from experimentally 
infected fish, none of the viral subtypes consistently met the old serological criteria (Sub-
committee on Inter-relationships among Catalogued Alphaviruses). This means that the 
current subtypes proposed on the basis of genetic work cannot actually be considered to 
separate subtypes within an alphavirus species using serology [101]. Earlier reports had 
already pointed towards this observation through experimental studies. For example, 
antisera raised against each of the six subtypes from different regions of Scotland, Ireland 
and Norway where used in neutralization assays and viral neutralization activity was 
detected in all when using isolate F93-125, the reference SPDV subtype 1 [99]. Despite the 
above described, the SPDV subtype division is widely accepted, used by the both industry 
and researchers and has been suggested to be maintained  [101]. 
 
The significance of this cross-neutralization study is the awareness that, independently of 
their subtype grouping, all different subtype strains are highly similar and serologically 
identical which, in essence, is a very positive aspect for vaccine development purposes.  
 
SPDV:  the disease  
 
The disease caused by SPDV in Atlantic salmon was initially recognised in Scotland, and 
reported as “Pancreas Disease” (PD) [102]. The empirical evidence to support a viral 
aetiology took more than a decade to be established [81], and its characterisation as an 
alphavirus induced condition even longer [103]. SPDV also affects other salmonid, namely 
the rainbow trout Oncorhynchus mykiss [104],  but for historical reasons and in spite of the 
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aetiological agent been found to be a closely related strain of the same virus, the disease 
affecting rainbow trout in fresh water is known as “Sleeping Disease” (SD) [52,82]. 
 
SPDV affects the UK (England, Scotland and Northern Ireland) as well as other important 
salmon producing countries, such as Norway [105] and Ireland  [106]. It has also been 
recorded in the USA [107], France [104], Spain, Italy [108], Germany [109], and recently 
Croatia [110], Poland [111], and Switzerland [112]. The Chilean salmon industry has 
reported both the disease and the agent to be absent in Chile [113] (and Marcela Lara, Head 
Animal Health Unit, Sernapesca, oral communication at Tri Nation meeting, Trondheim, 
Norway 2014). 
 
Although PD morbidity can be very high, the disease does not always induce acute mortality. 
An important aspect of PD impact on Atlantic salmon aquaculture is that survivors may 
recuperate but a proportion undergoes either reduced growth and weight loss (“runts”), or 
show few or no clinical and external signs. However, runts are notoriously thinner individuals 
(see Fig 12 A-B) and therefore the flesh quality is markedly reduced. Runts are also prone to 
other infections accounting for high cumulative mortality of up to 10-50% during the entire 
production cycle. The reduced flesh quality found at harvest time accounts for the overall 
cost of PD due to carcase rejection/downgrading. Atlantic salmon PD outbreaks can extend 
for several months and associated mortality varies widely, from 2-3% up to a record 80% 
reported in Norway following a traumatic sea water transfer [114]. A country wide study in 
Norway showed that specific mortality due to PD between 1999 and 2002 was over 5% of 
the cumulative mortality in 80% of the farm sites and exceeded 15% in 33% of the 
production sites [115]. Ireland reported a 50% cumulative mortality to be related to PD in the 
period from 1988 to 1992 [116], which was then followed by a significant reduction to 9-15% 
by 2003-2004 [117]. There is no official information on the prevalence PD in Scotland as it 
was never made a notifiable disease in the country as it occurs in Norway and therefore, 
records available represent fragmented data. An 18% prevalence of affected farms was 
recorded based on a nationwide survey during 2006-2007, using data from 74 out of 250 
active marine sites which were tested by real-time RT-PCR [118]. 
 
The overall cost of PD includes all those estimated in association with prevention, mortality, 
loss on growth rate, feed (due to poor feed conversion), additional staff time (required for 
treatments), and reduced carcass quality. This adds up to result in PD being a disease of 
high economic impact (Fig 11). For this reason, PD is considered the second most serious 





Fig 11: Convergence of all factors adding to the total losses of costs associated with prevention and 
control of PD. Source: adapted from MSS AQ003 project “Understanding the pathogenesis of salmonid 
alphavirus infection and improving strategies for management” report, with permission from Dr Malcolm 
Hall.  
 
Clinical signs and gross pathology 
 
PD outbreaks occur predominantly at the marine stage [117] and were typically seen in post-
smolts soon after transfer to the sea water, however can also affect later the bigger growing 
fish [120]. Common clinical features of PD include lethargy and lack of appetite which starts 
around two weeks before the outbreak; affected fish also display abnormal swimming, are 
unable to maintain normal position in the water column remaining close to surface, siding 
towards edges or corners, or conversely lying at the bottom of the cages [102,114,120,121]. 
The latter signs have been associated with skeletal muscle damage, which predisposes the 
infected animals to mechanical erosion and ulceration of the skin and fins [120,122]. Severe 
skeletal muscle damage has been confirmed to affect some aspects of the fillet quality [123] 
with changes on the colour when raw or after smoking process. Recently it has also been 
shown that fish undergoing SPDV infection develop skin dysbiosis (i.e. changes to the 
microflora), likely rendering them more susceptible to secondary bacterial infections [124]. At 
the end of an outbreak, affected survivors are dramatically thinner than non-affected fish (Fig 
12 A-B).  
 
At necropsy, marked reduction of body fat (especially in the region around the pyloric caeca), 
absence of food in the gastrointestinal tract, and frequent presence of mucoid yellow casts 
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are observed [122] (Fig 12 C). These signs, although consistently present, are not 
pathognomonic for PD. This is also the case with other, more inconsistently reported signs 
and observations, such as scale pocket oedema, exophthalmia, ascites, petechial 
haemorrhage, pale heart and pericardial blood (Fig 13). In fact, many of the latter signs are 
characteristic of other viral diseases, like petechial haemorrhage in IPN , pale hearts in HSMI 
(induced by Piscine Reovirus –PRV-) or pericardial blood in CMS (induced by Piscine 
myocarditis virus –PMCV-) [114].  
 
Fig 12: Gross pathology of SPDV infected Atlantic salmon. A) Marked reduced size and condition 
among post smolt affected at their first summer at sea (noticeable at bottom 3 individuals). B) runts 




Fig 13: Gross pathology of SPDV infected Atlantic salmon. Less frequent observations in SPDV 
infected fish A) marked exophthalmia and B) pale heart and pericardial blood (clot). Note also total 





The name PD came about as a result of the description in early reports of extensive exocrine 
pancreas lesions; total loss of acinar tissue and reduced peri-pancreatic fat [102]. These 
lesions were initially considered the hallmark of the disease [125]. However, further studies 
soon showed that striated muscle was also involved and that PD severely affected the heart 
and skeletal muscle tissues [105,106,126]. Degeneration, necrosis and inflammatory 
changes of the heart spongy ventricle and the white and red skeletal muscles were included 
in the description to conform the complete histological picture of this debilitating condition 
[106,114,120,121,127]. 
 
Overall, PD disease has been shown to have a complex presentation, with variable severity 
and lesion distribution. However, there is consistency in the timing of lesion development 
during the time course of outbreaks (Fig 14). The evidence that PD histopathological lesions 
developed in a sequential manner came from both experimental infections and natural 
outbreaks [106,120,121], following fish cohorts on different farms from sea water introduction 
to up to 6 months post introduction. These studies helped to explain early reports of natural 
outbreaks with different histopathological presentations, revealing that these differences 
were actually dependent on the time post infection correspond to acute, subacute, chronic 
and recovery stages. 
 
 
Fig 14: Pancreas disease: sequence of classical pathology alongside with molecular, virological and 




Although the primary target cell type/s at SPDV first entry into the host has not yet been 
identified, entry through gills, skin and intestine is assumed [96]. In any case, this has not 
been associated with detectable histopathological changes. The sequential pathology 
studies show that the first organ with histopathological changes is the pancreas, with a 
relatively short-lived acute phase occurring within the first week post infection within the 
viraemic phase which last between 2 to 3 weeks, peaking half way this period. Early 
changes include individual pyknosis of exocrine pancreatic acinar cells, cell rounding, fine 
vacuolation and with features of apoptosis present, with occasional mild to moderate 
mononuclear cell infiltration. Extensive to total loss of acinar cells follows towards the end of 
the viraemic phase, associated with a variable peripancreatic inflammatory response 
including steatitis and serositis (Fig 15). Pancreatic changes are followed immediately by 
focal and acute lesions in the heart between 1-2 wpi, with hyper eosinophilia of scattered 
pyknotic cardiomyocytes (necrosis) and mild focal inflammation (Fig 16). This is followed by 
early skeletal muscle lesions (starting approximately 3wpi) where individual fibre necrosis 
and degeneration in white muscle can be observed (Fig 17). While the pancreas can start 
recovering between 4-5 wpi, the striated muscle lesions progress and advanced changes in 
heart and skeletal muscle peak between 6-8 wpi. These are seen as multifocal 
cardiomyocyte necrosis and subendocardial and myocardial focal to diffuse inflammatory cell 
infiltration in the heart (Fig 16), which in some cases also show macrophage infiltration of 
necrotic fibres, vacuolation of the spongy trabecular ventricular myocardium, as well as 
proliferation of endocardial cells. In the skeletal muscle, the myofibers are degenerated and 
inflamed with endomysial fibrosis, which is most severe in the red muscle, but also affects 
the white muscle (Fig 17). 
 
At the later stages (by 9-10 wpi) pancreas fibrosis can be observed, particularly in fish that 
became runts  [114]. In clinically healthy fish at 9-10 wpi, the pancreas has been observed to 
have very mild or no fibrosis, and it has been suggested that these differences depend on 
the level of inflammation during the acute phase. In addition, the striated muscle may also 
show regeneration capacity in recovered fish [126–128]. At the later stage, SPDV can 
develop into a chronic condition characterised by a severe reduction in the peripancreatic fat, 
the inflammation at the junction between ventricular compact and spongy myocardial layers 
and skeletal muscle endomysial fibrosis. A significant sub-endocardial fibrosis has been 
reported which may potentially indicate susceptibility to stress-related heart-failure [123]. 
This finding may relate to earlier descriptions of chronic PD been previously known as 





Fig 15: Atlantic salmon affected by SPDV. Light microscopy of pancreas stained with H&E.  A) 
Overview at low magnification of the pancreatic tissue interspersed among the pyloric caeca (PC). 
Note loss of pancreatic architecture, reduced peri-visceral fat and patches of intense basophilic cells 
(arrow) suggestive of periacinar infiltration. B) Early changes in exocrine cells with degeneration and 
scattered pyknotic nuclei (arrow heads). Note foamy aspect of the cytoplasm rendering a vacuolated 
appearance. C) A patch of necrotic tissue to the right of the image shows a poor stain uptake of the 
degenerated cells, with higher eosinophilia (bright pink –orange colour) and pyknotic nuclei (arrow 
heads) in the absence of inflammatory cells. Note the adjacent area to the left shows normal acinar 
tissue containing zymogen granules (white arrow head). D) Total loss of exocrine pancreas noted in 
the peri-visceral fat tissue, a characteristic of chronic PD. F). Few patches of acinar cells can be 
observed in a recovering pancreas. Note a reduced cell size in the periphery. F) Higher magnification 







Fig 16: Atlantic salmon affected by SPDV. Light microscopy of the heart stained with H&E. A) 
Ventricular spongy myocardium showing scattered, strongly eosinophilic shrunken, cardiomyocytes 
(hyaline necrosis). B) Higher magnification shows the nature of individual cells necrosis (arrow heads) 
of cardiac muscle with very mild infiltration (lower left corner). C) Multifocal myocardial necrosis and 
formation of a larger coalescence lesion in ventricular spongiosum. D) Ventricular spongiosum showing 
slight thickening of the endocardium (arrows) and intra myofiber pale areas (stars) due loss of striation 




Fig 17: Atlantic salmon affected by SPDV. Light microscopy of the skeletal muscle stained with H&E. 
A) Low magnification overview of a section at the lateral line level shows evidence of severe 
degeneration and necrosis of both white and red skeletal muscle. B) Higher magnification showing the 
severe degeneration and necrosis affecting both red muscle (left) and white (right) skeletal muscle. 
Influx of inflammatory cells can be noted. C) High magnification showing necrosis of a single myofiber, 
with presence of phagocytic cell within (arrow). Note rounding of neighbouring, focal inflammation and 
mild thickening of the endomysium (upper left). D) High magnification of two individual WM fibers 
undergoing complete degeneration and necrosis (stars). E) Red muscle severe necrosis and 
inflammation. Note nearly hollow myofibers where only the endomysium is still visible. F) Severe 







Disease diagnosis   
 
Preliminary PD diagnosis is based on clinical signs and histopathology. This is followed by 
the isolation of the virus, serology, immunofluorescence and molecular RT-PCR detection, 
which are used for confirmation [122]. 
 
Although SPDV can be grown in culture, the virus proved historically challenging to isolate 
from field cases [52,98,129,130]. It is not uncommon that samples from fish with overt 
consistent PD clinical and histopathological signs and reliable PCR positive results, do not 
result necessarily in positive viral isolation. Isolation has been attempted by different 
groups/laboratories using a range of cell lines including Chinook Salmon Embryo (CHSE-
214), Atlantic salmon fibroblast (AS-6), bluegill fry (BF-2), epithelioma papillosum carpio 
(EPC), rainbow trout gonad (RTG-2), Asian Grouper Kidney (AGK) and Chum salmon heart 
(CHH-1) cells [98,131,132]. Results point to a consensus that CHSE-214 yields the best 
results as a compromise of titres and detection of cytopathic effect (CPE). Variable success 
in general has been assigned to several factors including initial low viral loads and potential 
presence of virus neutralizing antibodies on the tissue samples [133]. Also, the tissue of 
origin for sampling has been reconsidered after work on virus tropism. This work determined 
that the traditionally used head kidney sample was not the most suitable, and shifting 
sampling towards the heart clearly improved successful isolation rates [134] (and internal 
MSS diagnostic reports). Finally, a recent investigation gives a reasonable hypothesis to 
explain the difficulties in viral isolation. Based on sequencing of SPDV subtype-3 isolates 
from natural infections in Norway, it was found that numerous deleted mutants (defective 
viruses containing genome deletions) are generated during the natural infection cycles. The 
presence of these “defective” viruses within infected populations/tissues, has been 
suggested as the possible explanation for the difficulty for cell culture isolation[132] and 
could relate to previous reports on culture adaptation requirements[135] and laboratory 





Factors that may influence the disease prognosis include water temperature and season that 
can accelerate the infection dynamics (duration and mortality rates), differences in virulence 
of subtypes/isolates [99] and host differential susceptibility [136]. Additionally, any stressful 
husbandry practices such as lice treatments, crowding or any other practice triggering 







The differential diagnoses of PD include nutritional myopathies and specially other viral 
conditions of Atlantic salmon, such as IPN at the pancreatic level and CMS and HSMI. 
Clinical presentation of PD has been described above (5.1) a for CMS and HSMI autopsy 
findings contribute to differentiation as they point towards circulatory failure, including 
sometimes the presence of blood clots in the heart cavity. There may also be congested 
liver, splenomegaly and petechial (pin-prick) haemorrhages in the adipose tissue. 
Histologically, while the heart is the common organ involved in all 3 conditions and some 
lesions can be very similar depending of the time course of the disease, the presence of 
myopathy also in the red and white skeletal muscle allows differentiation of PD from CMS for 
example. Presence of multifocal zonal or patchy liver necrosis as a secondary lesion 
correlates with heart failure in HSMI, and this occurs while the pancreas remains unaffected 




Prophylaxis remains a first goal on the health maintenance of any livestock production. 
However, for the majority of farming sites located in endemic areas it is difficult to avoid the 
infection. SPDV viraemic phase is known to occur early in the infection cycle and correlates 
with the peak of shedding [99,140] and therefore it has high potential for water-borne 
spreading. Additionally, fat droplets in the water surface, originating from infected dead 
salmon [25,140], faeces and mucus [141] have been also shown to carry viable viral 
particles.  
 
Among the factors that regulate the onset of a PD outbreak temperature influence has been 
shown to be inversely related the disease incubation period, with shorter incubation at higher 
temperatures [51]. Fish movements are well identified risk factors for introduction into a site, 
and both site to site transfers during production or from farming site to harvest can be 
involved [122]. Additionally, there is a potential for fish carrying the virus for up to 71 wpi 
prior to clinical disease outbreak [142], and so the risk from movements of infected fish that 
present no signs of PD is high. 
 
A thorough and updated review on the epidemiology of PD has been recently published [96]. 
It showed that, in spite of the impressive amount of information generated after decades of 
study of the condition, there has been yet no scientific evaluation of current on-site bio-
security measures, and information on the impact of available mitigation and control 
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strategies is limited, particularly for Ireland and Scotland. A notable exception is in Norway, 
where a project by the industry (“PD free”) aiming to reduce PD outbreaks, associated losses 
and spreading of the disease was started in 2007. Briefly, from 2008 the Norwegian 
coastline was divided into 2 administrative zones separated by a production-free area of 10 
nautical miles and at the same time, industry then initiated an extensive vaccination program 
involving most marine salmonid farms. This was associated with a 24% reduction in 
outbreaks from 2007 to 2009 and an overall reduction of 10% for the period 2007–2010. 
Overall the synergic approach showed it had a positive effect in reducing the number of 
outbreaks and also in decreasing cumulative mortality and the number of fish discarded at 
slaughter [143]. 
 
A common practice in controlling PD to reduce risk is to use PD resistant ova generated from 
breeding programs and/or the implementation of vaccination schemes. Vaccination has been 
seen as a promising strategy since the early years of PD when it was already shown that 
pre-exposed fish became resistant to subsequent challenges [144] and that 100% of the fish 
were seroconverting by 3 weeks after experimental infection [121]. Also, passive 
immunisation by administration of antisera from naturally and experimentally infected fish, 
resulted in protection against subsequent challenge[145]. Soon after these studies, the first 
reported vaccine trial was performed using a simple formalin-inactivated virus tested by IP 
injection in fresh water parr [122]. Fish were resistant to infection when challenged 4 weeks 
later. Subsequent studies indicated that development of a commercial vaccine was possible. 
Indeed, in 2007 a commercial vaccine based on inactivated SPDV became available 
(Norvax® Compact PD, Intervet International B.V, currently MSD Animal Health)[143] and 
was used for the extensive vaccination program associated to the PD free project. While it 
was shown the vaccine had positive effects, controversy remains as to the overall 
effectiveness as PD cases in Norway did not reduce as much as expected.  
 
For many years, there was a monopoly on the commercial supply of vaccine due a patent 
filed by Intervet (currently part of MSD Animal Health) that prevented the commercialization 
of alternative formulations. This was an outstanding issue for many years until 2017, when a 
decision by the Norwegian Supreme Court approved a vaccine formulation by another 
company (https://www.pharmaq.no/updates/pharmaq-s-pd-va/). This has opened the door 
for other companies to offer alternative options. For example, the vaccine above mentioned 
confers improved protection to PD, both when administered alone or as a component in a 
polyvalent vaccine  [146].  
 
This has enabled the investigation of other approaches, such as a recombinant (fully 
attenuated) salmonid alphavirus vaccine  [147], as well as DNA vaccines. Two formulations 
using the latter approach has been recently reported to provide strong protection against 
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SAV3 infection without addition of IFN plasmid as adjuvant [148]. Progress towards 
commercialization has been made  [149,150] and recently, the European Medicines Agency 
(EMA) recommended granting a marketing authorisation in the European Union (EU) for 
Clynav, a DNA vaccine to protect Atlantic salmon against PD caused by salmon alphavirus 
subtype 3 [151]. 
 
Other approaches to vaccination may include the use of replicons. Alphaviruses have been 
widely used in reverse genetics and protein expression systems, and self-amplifying RNA 
(replicon) vectors have been developed from different alphaviruses including Semliki Forest 
virus (SFV) [56,152]. In these alphavirus-based replicons, the subgenomic second open 
reading frame (ORF) is replaced with that of the gene of interest (GOI) and its expression is 
then executed by the alphavirus replication apparatus. Replicons are useful for basic studies 
and in vivo expression of GOI but can also be used as vector system for vaccination [153]. 
Recently, a SPDV replicon was shown to be active in cells from fish, mammals, insects and 
crustaceans, producing GOIs over a wide temperature range (4–37 °C) [79]. Moreover, a 
successful precedent of immunization against another important salmon viral disease, 
namely ISA, was recently reported using a Salmonid alphavirus-based replicon vaccine 
[154]. The use of this approach clearly opens new perspectives for the development of viral 
fish vaccines, together with the now approved DNA vaccines approach.  
 
Effective vaccination is useful in limiting PD damage within farms, and also limits its spread 
to other farms. Infection pressure has been shown to have a strong effect on the probability 
of a PD outbreak at neighbouring farms, and success with vaccination approaches is an 
important tool to reduce the risk. Effects are due to a diminished infection pressure within 
and between farms, by reduction of the severity and mortality resulting in a significant 
decrease in virus shedding, even if vaccinated fish become infected [155,156].  
 
Viral tissue tropism, pathogenesis and host response 
 
In the mosquito host (Aedes albopictus), virus has been observed to reach the head ganglia, 
salivary glands, anterior and posterior midgut and thoracic muscle, being more persistent in 
the fat bodies; haemolymph, the hindgut, and the tracheole-associated cells [157]. In the 
vertebrate hosts, on the other hand, initial sites of detection include skeletal muscle, liver, 
lungs mesenchymal cells, fat cells, chondrocytes, fibroblasts, osteoblasts, neural and glial 
cells and macrophages in the skin. It often leads to infection of the draining lymph node and 





SPDV, has also a wide range of organ/tissue tropism including the pseudobranch and gills, 
heart muscle (atrium and ventricle), head kidney, pyloric caeca (specifically the fat 
associated pancreatic tissue), white and red skeletal muscle, brain, liver, spleen, head 
kidney leucocytes and transiently, in the serum [92,133,134,160–162]. From all these, the 
most suitable tissue for molecular diagnosis in Atlantic salmon, irrespective of the fish 
disease status, was found to be the heart and the pseudobranch [134], with brain tissue 
coming up also consistently positive although this is not a tissue that is frequently or 
consistently sampled. In a Norwegian study, A salmon infected with SPDV 3 viral RNA was 
detected using real-time RT-PCR in surviving experimental animals six months after infection 
[134]. Authors noted that such detection might not necessarily reflect the presence of active 
virus replication as the assays cannot estimate the precise amount of viable, infectious virus 
particles. However they consider that this raises the possibility of survivors becoming life-
long asymptomatic carriers.  
 
The manifestation of alphavirus infections, particularly in the several conditions affecting 
humans, is associated with the local effects of the virus replication in the target 
organs/tissues, such as arthritis when replicating in joints or encephalitis when replicating in 
the brain tissue. The associated local inflammatory response is believed to contribute to 
some of the tissue damage and disease symptoms [160,163,164]. This however may vary in 
the different alphavirus. In SPDV for example, the recognised main target tissues such as 
exocrine pancreas, striated heart and skeletal muscle, often show severe lesions but a range 
of inflammatory responses. Other infected tissues, such as gills, pseudobranch or kidney, 
often do not have observable damage despite harbouring the virus for extended periods of 
time during infection [92,162]. 
 
Virally induced cell death is an important aspect of viral pathogenesis. Apoptosis is 
frequently involved [165] and has been reported in A salmon for other viral diseases, such as 
ISAV [166] or IPNV  [167]. With some exceptions, alphavirus infection of vertebrate hosts is 
known to result in cell death by induction of apoptosis [56]. Similarly, SPDV-associated 
apoptosis has been reported in pancreatic [168] and cardiac tissues [169]. However, the role 
and relevance of apoptosis in SPDV in vivo infections, its pathogenesis, its effect on virus 
competence and its replication efficiency still require further investigation [170].  
 
Fish are known to be capable of mounting a strong and protective innate and acquired 
immune response to many viruses, as evidenced by the presence of a potent and functional 
type I interferon (IFN) pathway, and by the effective outcome of a number of vaccines that 




The type I IFN response is considered a robust first line of antiviral innate response in 
vertebrates [173]. Type I interferons (IFN α/β) and the corresponding interferon-stimulated 
genes (ISGs) such as mx 1,2 and 3 are known to play a pivotal role in the defence against 
virus, and their role is well described in alphavirus in vivo infections [174]. The host cell 
recognizes viral RNA by various receptors, starting a signal process that can lead to the 
synthesis and secretion of IFN. All nucleated cells have this capacity to respond and produce 
type I IFN. In brief, the engagement post recognition between pathogen-associated 
molecular patterns (PAMPs) and pattern recognition receptors (PRRs), triggers the activation 
of transcription factors (TFs), the subsequent expression of IFN inducing in turn the ISGs 
[175]. Once secreted, IFNs act both in auto- and paracrine manners, inducing an antiviral 
state inhibiting viral replication and preventing the infection in infected and un-infected cells, 
respectively [173].  
 
Although there are relatively fewer studies in fish, there is abundant evidence of the role 
played by IFNs in protecting against viral infections including against SPDV, both in vivo and 
in vitro [168,176,177]. Recently, in addition to secreted IFNs, fish were found to possess a 
functional intracellular IFN (iIFN) [178] but its involvement in the immunity to viruses remains 
unclear. For a full review of the innate immune responses of salmonid fish to viral infections 
see review by Collet 2014 [48].  
 
In mammalian hosts, a strong inhibition of the IFN response has been described as essential 
for alphaviruses to establish productive infections, such as Sindbis (SINV) infections 
triggering a general host cell shut-off affecting the induction and expression of IFNs and 
ISGs [179,180]. However, if the host cells are IFN treated prior to infection, ISGs were 
readily expressed and virus replication is severely reduced [179]. The former case has been 
shown for SPDV in vitro infections of an Atlantic salmon head kidney cell line (TO), where 
IFNα showed to induce protection against a subtype 3 SPDV in a time dependant manner 
related to exposure to IFN prior to infection [181]. Induction and expression of the IFN 
inducible gene Mx has been widely used in studies of fish immune response [176,182].  In 
Atlantic salmon both naturally and experimentally infected salmon, positive correlation has 
been demonstrated between IFNα-stimulated gene mx expression and cell protection 
against SAV-induced CPE [181]. 
 
In terms of the humoral response, antibodies (Ab) were found to be a relevant part of 
protection against PD since the early experimental infections. During these, effective SPDV 
neutralizing Abs were detected after 10 days post inoculation and 11 days later in the 
cohabitant fish [121]. The proportion of fish seroconverting increased from 60% 2 wpi to 
100% at 3 wpi. From this point onwards, fish displayed an overall increasing titre in both 
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inoculated and cohabitants until termination of the experiment at 8 wpi. Even 12 weeks post 
inoculation, fish have been shown still to retain a good level of Ab titres (see Fig 14). 
 
Finally, in a very different approach to examine the response in Atlantic salmon to infection 
with an SAV 3, the virus induced an important shift in the skin bacterial community 
composition [124] and the resulting unbalanced microbiota has a decreased abundance of 
Proteobacteria while opportunistic taxa increased (Flavobacteriaceae, Streptococcaceae and 




Knowledge gaps, the future and thesis objectives 
 
Although PD has been recognised for over 30 years, it remains a significant problem for the 
salmon farming industry in terms of both profitability and welfare. To assist industry in 
Scotland and Norway in meeting the policy objective of increased growth over the next ten 
years, a continued support based on sound scientific evidence is required.  
 
Knowledge gaps in relation to disease control are regularly identified and discussed at 
meetings such as the “PD Tri-nation”, a forum started over a decade ago that brings together 
interested parties from the salmon farming countries (initially Norway, Scotland and Ireland) 
and includes industry, science-academia and policy representatives. Since it was 
established in 2005, it has provided an open forum for rapid dissemination of experience, 
new knowledge and efforts to help improve control strategies and, importantly, to identify the 
new or the permanent outstanding challenges. 
 
Marine Scotland Science (MSS) supported a research programme on salmonid alphavirus 
for several years and this thesis project was initiated as a consequence of a Tri Nation 
meeting in 2009 where among others, the following knowledge gaps were identified and 
became the framework for this PhD project: 
 
1. Increased knowledge on the virulence/pathogenicity of the virus subtypes 
2. Improved experimental models for transmission and disease mechanisms 
3. Improved knowledge on the virus and on possible natural hosts 
 
Therefore, with the general objective to improve or develop new experiment approaches 
especially applicable to Atlantic salmon, the current thesis presents the results of the work 




To contribute with knowledge gap 1 (“Increased knowledge on the virulence/pathogenicity of 
the virus subtypes”), I initially used an in vivo classical intra peritoneal infection with a single 
sampling time point at 35 dpi to establish the virulence of MSS available different subtypes 
as well as isolates within subtypes. These data were used to determine the most appropriate 
isolate for further work based on virulence, assessed through histopathology and molecular 
results. It also provided for the preliminary assessment and comparison of tissue tropism 
which became the basis for the selection of heart, brain and skeletal muscle among the 7 
tissues examined (heart, brain, skeletal muscle, kidney, liver, pancreas and spleen) for 
testing in further in vivo challenges.  
 
In relation to knowledge gap 2 (“improved experimental models for transmission and disease 
mechanisms”), I developed a working cohabitation model which at the time, was not 
available at MSS or had been reported to the best of my knowledge. Experimental work was 
performed at VESO –Vikan (Norway) and the model applied successfully established 
infection in the co habitant fish. The experiment was followed for 2 months with 8 sampling 
time points, and allowed to measure the expression of the viral and mx (component of the 
immune response) genes at different tissue levels. Additionally, this experiment allowed me 
to contribute with a contemporary MSS project working on viral assessment by non- lethal 
sampling. Extra samples (blood) taken for it were used to validate the capacity of a reported 
cell line to detect the viral infection. The work demonstrated that results obtained from the 
blood of infected fish closely reflect those from sampling at the organ level, validating the 
option for a non-lethal approach, in line with the 3R principles (reducing, refining, replacing) 
in animal experimentation (collaborative published paper as co-author, under Annex). 
 
After confirming the relevance of the heart during the in vivo infections, the in vitro part of the 
work started, focused on introducing a cellular model based on embryological tissue of 
Atlantic salmon, to establish an in vitro species-specific, cardiac model.  
The Salmon cardiac primary cultures (SCPCs) was characterised, different tools to work with 
the model were explored and importantly, viral infection permissiveness was tested using 
different cardiotropic viral agents (chapter 3 Paper 1). The model was further used to assess 
potential influences of the embryo genotype on the outcome of viral infection, which showed 
measurable differences in the viral and the mx gene expression between SCPCs originated 
from ova of different traits (chapter 4 Paper 2). This later experiment also included the 
description of associated pathological changes by ultrastructure examination using 
transmission electron microscopy (TEM).  
 
Finally, to contribute to knowledge gap 3 (“improved knowledge on the virus and potential 
natural host”), by drawing from the extensive literature in mammalian alphavirus work the 
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SCPC model was used to examine and describe the SPDV infection cycle by ultrastructural 
by TEM. This resulted in novel insights on the virus replication cycle that had not been 
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Historically, two new salmonid conditions, Pancreas disease (PD) and Sleeping disease 
(SD) were independently reported in Scotland and France affecting Atlantic salmon (Salmo 
salar L.) and rainbow trout (Oncorhynchus mykiss), respectively (1,2). Evidence of their viral 
aetiology came between 1995 and 1997, when both diseases were associated with an 
enveloped virus, morphologically consistent with a member of the Togaviridae family (3,4), 
and later classified within the genus Alphavirus (5,6). It took a few more years -until genomic 
sequencing became widely used- for recognition that PD and SD are induced by closely 
related isolates of the same virus species (7).  
 
While SPDV infections may affect Atlantic salmon both in fresh and sea water, it is 
recognised that the most serious effects are predominantly during the sea water phase (8,9). 
An epidemiological study performed in Norway followed fish cohorts along the production 
cycle from the fresh water, transfer to sea water and sea water growing phases (9). Their 
results showed that fish from sites with no detectable viral infection by RT-PCR, antibodies 
or pathological changes consistent with PD while in the fresh water, after transfer to sea 
water ~64% of the sites were positive. It is believed that SPDV challenge in sea water occurs 
from soon after fish are transferred as “post smolts” (developmental stage after smoltification 
process is completed and the fish has moved or been transferred to full sea water) and 
throughout the production cycle. PD can therefore affect all sizes at sea water and has been 
reported in Atlantic salmon up to ~6 kg (9).  
 
Among the isolates recovered from Scottish salmon farms through diagnostic work at the 
Scottish national reference laboratory (Marine Scotland Science –MSS-), subtypes 1 and 2 
appear as the most prevalent followed by 4 and 5 (10), and some of these isolates were 
available for experimental work. MSS had long experience with SPDV in vivo challenges 
however, they predominantly had been performed by intraperitoneal (ip) injection in parr fish 
(fresh water stage), either with infected tissue homogenates (11) or with purified virus 
isolates (12). At the time this PhD project started a cohabitation experimental model that 
would reproduce the infection in post smolts, in sea water - the developmental stage and 
environment when predominantly salmon are challenged in the field- had not yet been 




A pantropic tissue distribution for SPDV had been previously suggested (13) based on 
experimentally ip infected Atlantic salmon with wild-type subtype 3 infectious material (tissue 
homogenates) derived from natural infections, and with isolate F93-125 (founder of subtype 
1 and derived from the original PD case) (3). All the tissues examined (pseudobranch, gill, 
atrium, ventricle, head kidney, pyloric caeca and pancreas (hereafter refer as pancreas), and 
skeletal muscle), became RT-PCR positive at some point during the examined period of up 
to 190 dpi. Peak of viral detection for the homogenate inoculated fish was between days 21 
to 60 and these fish showed a higher and earlier detection than those injected with F93-125 
(13).  
 
As referred to in the Introduction, six SPDV subtypes had been recognised (14) and their 
geographical distribution been reported (15,16) and summarised in Table 1. Early on it was 
noted that subtype clustering did not necessarily reflect infectiveness, mortality, virulence, or 











Sub 1 (PD) UK (Scotland- 
Northern Ireland), 
Ireland 
Atlantic salmon * 
Rainbow trout ** 
sea water* 
fresh water** 
Sub 2 (SD) UK-Continental 
Europe 
Rainbow trout fresh water 
Sub 2 (PD) Scotland -Norway Atlantic salmon sea water 
Sub 3 (PD) Norway Atlantic salmon 
Rainbow trout 
sea water 
Sub 4 (PD) UK(Scotland- 
Northern Ireland), 
Ireland 
Atlantic salmon sea water 
Sub 5 (PD) Scotland Atlantic salmon sea water 
Sub 6 (PD) Ireland Atlantic salmon sea water 
 
Table 1: SPDV subtypes and their geographical distributions affected species and environment 
(adapted from OIE Manual of Diagnostic Tests for Aquatic Animals, chapter 2.3.6). 
 
For this thesis work there was an initial attempt to set infection by co-habitation at MSS using 
isolate 4640, an MSS subtype 1 SPDV. In brief, 128 post smolts (~150 g) distributed in four 
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tanks were allocated to x 3 replicates for treatment and x1 for controls. Half of the fish on 
each tank (16/32) were ip (0.2 ml of 2 x 106 TCID50 /ml) for the treatment tanks and 0.2 ml of 
culture media CHSE-214, for control fish). Based on previous reports (19) the expected time 
of infection of cohabitants (ch) was estimated around 14 days post infection (dpi) therefore a 
window between days 10 and 20 was set to be thoroughly covered by five sampling points at 
days 5, 8, 10, 15, 20, followed by additional three time points at 35, 45 and 60 dpi. At each 
point 2 ch fish per tank were sampled (6 x treatment and 2 controls). Seven tissues were 
sampled (pyloric caeca for pancreas, skeletal muscle, heart, liver, brain, kidney and spleen) 
and testing performed by quantitative RT-PCR. However, the experiment was stopped at 45 
dpi as results from point 35 dpi became available showing there was still no viral signal at 
any fish or tissue, and all remaining ip fish were sampled. The ip fish testing showed ~70% 
of this them were negative for SPDV by RT-PCR. It was as results of this failed attempt that, 
to account for the potential effect of hypothetical differences in isolate infectiveness, the 
following step towards developing a successful cohabitation model was to do a previous 
selection of a highly infective isolate from those available in-house, by means of a 
comparative ip challenge. 
 
The aim for the work in this chapter was therefore to select candidates among 6 SPDV 
isolates representing 3 different subtypes from Irish and Scottish salmon farming cases. The 
challenge methodology was by ip and candidates would be chosen based on the frequency 
of infection and viral load among seven tissues (heart, kidney, liver, pancreas, spleen, brain 
and skeletal muscle) as measured by quantitative RT-PCR at a single time point (30 dpi). 
 
Hypothesis: inter and /or intra subtype differences on infectiveness and tissue tropism 
among SPDV isolates can be assessed by RT-PCR viral load measurement on ip injected 
fish after 30 days post infection.  
 
 
Materials & Methods  
 
This study was carried out in strict accordance with the UK Animals (Scientific Procedures) 
Act 1986 (ASPA) under the project licence PPL3965. The protocol was approved by the 
Marine Scotland Ethical Review Committee. The challenge used 192 Atlantic salmon post 
smolts of an average weight of 200 ± 10 g already adapted at water full salinity. A single 
terminal sampling time point was set at 30 dpi. Fish were sourced from a farm with a history 
of freedom from SPDV. The SPDV infection-free status of the stock was further confirmed by 
pre-screening a subset of 30 fish using the same methodology described below for the rest 




The experimental design included eight tanks of 1 x 0.8 m where fish were equally 
distributed (x24/tank) and allocated either to as “Control” (culture media) or “Treatment” 
(SPDV isolates) tanks (Fig 1) at a stocking density of ~8 Kg/m3. Isolates tested represented 
SPDV subtypes 1 (x3), 2 (x2) and 5 (x1) (Fig 1). Subtypes 1 and 2 were chosen due their 
frequent presence in Scottish field cases and subtype 5 due the additional contemporary 
reporting of a “subtype 5 like” isolate in the common dab Limanda limanda, a wild fish 
suggested as a potential wild reservoir for the virus (20). These isolates were propagated at 
the MSS laboratory using Chinook salmon (Oncorhynchus tshawytscha) embryo cells 




Fig 1: Experimental setting, subtype identification, dose and origin of the 6 SPDV isolates used for the 
intra and inter-subtype comparison. Dose in TCID50, SW= sea water, FW= fresh water. 
 
Anaesthesia was performed in a solution of tricaine methanesulphonate (MS222 Sigma, 
Irvine, UK) at a dose of 80 mg/L before proceeding to ip inject fish with a dose of 0.2 ml of 
inoculums at doses contained in Table 1. Water temperature was maintained at 14° ± 1°C, 
flow at 300 L/h , and fish were fed commercial pellet ad libitum over the 30 days.  
 
At termination of the experiment all fish were euthanized by an overdose of anaesthesia and 
weighed before necropsy. Sampling procedure was performed by immediately dissecting 
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open of the coelomic and pericardial cavities to collect samples into RNA later from pyloric 
caeca (PC), skeletal muscle (SM), heart (H), liver (L), brain (B), kidney (K), and spleen (S). 
 
The viral load was measured as transcription of the nsP1 gene and the antiviral response 
was measured as expression of the mx gene, and normalized against elongation factor α (elf 
α) (21). In brief, from each sample 9.6 µl of total RNA and 1.25 µl 50 µM oligo-d (T)16 were 
mixed and heated to 70 °C for 10 min and chilled on ice. A final volume adjusted to 25 µl 
was done by adding a master mix comprised of 1x RT buffer (25 mM Tris–HCl pH 8.3, 37.5 
mM KCl, 5.5 mM MgCl2), 0.5 mM each dNTP, 0.4 U RNase inhibitor and 1.25 U Multiscribe 
Reverse Transcriptase. The reaction was incubated at 48 °C for 90 min, heat inactivated at 
95 °C for 5 min and stored at -80 °C until use. Real time qPCR assay was performed using a 
Roche LC480 System (Roche). The TaqMan probes and primers used to amplify the elf, mx 
and nsP1 genes have been previously reported (22). One µl cDNA was added to the mix on 
each of a 96-well optical plate (Roche): 10 µl of TaqMan 2x PCR mix with UNG (Applied 
Biosystems), 8 µl of dH2O and 1 µl of a 20x mix containing forward primer (18 mM), reverse 
primer (18 mM) and probe (5 mM). The standard cycling conditions were 50 °C for 2 min, 95 
°C for 10 min followed by 50 cycles of 95 °C for 15 s and 60 °C for 1 min. The approach to 
estimate the amplification efficiency was the slope-derived calculation from the standard 
curve method using the cycle threshold (Ct) value determined by the maximum secondary 
derivative method; values were converted into expression levels normalised against the 
housekeeping reference gene (elf), using a standard curve. Quantitative RT-PCR was 
performed in triplicates on the same sample and the average result presented. Elongation 
factor α (elf α) expression was used as an internal control to normalise gene expression 





Using an ip injection route, all isolates successfully established some level of infection by 30 
dpi (i.e. detectable virus in tissue). Viral presence as measured by RT-qPCR varied between 
the seven tissues examined. Overall, irrespective of the isolate the heart had the higher 
number of positive results, followed by skeletal muscle and brain (Fig 2). When summarizing 
the frequency data, isolate F07-220 (subtype 1) showed the overall higher frequency of 
positive individuals in all tissues, followed with equal percentages by isolates 4640 (subtype 





Fig 2: SPDV viral distribution frequency per tissue and isolate at 30 dpi (after PI challenge). 
 
 
Table 2: Frequency of (+) fish by tissues and isolate measured at 30 dpi. Reduced number of total 
samples for some tissues is due to some samples giving undetermined PCR results (suggesting 
sample was too small or lost). The % of total (+) samples by tissue in all isolates is given in the lower 
horizontal row and the % of total (+) samples by isolate from all tissues, in the far-right column.  
 
 
For the 4 isolates with the higher percentage of total infected samples from all tissues (F07-
220, 4640, 4639 and 4607), the individual Ct values of all positives recorded in the three 
main tissues (heart, brain and skeletal muscle) are presented in Fig 3. 
 
The average Ct value of all positive samples by tissue for the same 4 isolates is presented in 
Fig 4 and data represented as ratios of the viral nsP1 expression relative to the elf (average 





 Fig 3: Heart, brain and skeletal muscle individual Ct values of all fish from the 4 isolates with higher 




 Fig 4: Average Ct values from all the positive tissues in the 4 isolates with higher than 18 % total 
infected samples. . Errors bars represent standard deviation; where not visible this is due the low 








Fig 5: Average of the relative expression of viral nsP1 gene in all positive fish per tissue, in the 4 
isolates with higher than 18% of infected tissues. Errors bars represent standard deviation, where not 







The average in weight gain from all fish per tank after 30 dpi relative to average weight at start is 
presented in Fig 6. All infected groups showed relatively decreased weight gain compared to the 
control group. Among infected fish isolates F07-220 and 4640 (subtype 1) had comparable and 
relatively lower weight gains. Isolates 4639 (subtype 1), P42 and 4607 (subtype 2) had intermediate 
relative weight gains, and isolate 4638 (subtype 5) had the highest relative weight gain. 
 
 
 Fig 6 Average and standard deviation of total body weight gain per isolate from the beginning of the 





While currently inter and intra subtype variations on SPDV infectivity and pathogenicity are 
acknowledged and reported (18), at the time this work was carried out it was essentially 
suspected from diagnostic observations, preliminary experimental work and a subject of 
discussions among colleagues working in the discipline.  
 
At the initial attempt of establishing infection by cohabitation with isolate 4640, a 50/50 ratio 
ip to ch fish failed to establish infection after 35 days. The ip fish examined at terminal 
sampling 45 dpi showed only ~30% had a positive SPDV signal at one or more of the heart, 
brain and /or skeletal muscle samples (data not shown).  
Different factors may have determined the failure on transmission on that experiment, 
including an insufficient number of ip shedders, the effect of potential procedural errors on 
dose preparation or deliver, changes in virulence  due passages and culture adaptation 
(18,23,24) or a potential variable susceptibility of the fish stock as previously reported (25). 
However the negative result could also have been due, as here hypothesized, to differences 
in infectivity between isolates for which there was no published evidence at the time. The 
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reported experiment in this chapter was therefore designed to assess these differences in a 
range of isolates available at the MSS laboratory. 
 
The experimental comparison using purified isolates from outbreaks in Scotland (x5 isolates) 
or Ireland (x1), used detection of SPDV RNA in tissues after 30 dpi and differences in weight 
gain data to decide on best candidates. The 30 dpi time point for terminal sampling was 
chosen based on results from previous reports on ip infection challenges (13), and although 
earlier time points could have been chosen, it was meant to cover a window to allow 
detection of viral RNA in the skeletal muscle, which was reported to occurs later during the 
infection.  
 
Results pointed to 4 isolates with a better potential i.e the three subtype 1 isolates (F07-220, 
4640 and 4607) and one of the subtypes 2 (4607). It is necessary to acknowledge the 
inoculums doses were different for each isolate, particularly those of F07-220 and 4639 
lagging behind ~2 orders of magnitude compared to the others. This was indeed an 
unfortunate mistake due the eagerness to initiate the experimental work and where 
information on titration became available only after the experiment started. Interestingly 
however, in spite of receiving the highest dose, isolate P42 in this experiment had the lowest 
viral level overall, while isolates F07-202 and 4639 with the lowest relative dose of infection, 
were among the highest.  
 
Isolates 4638 and P42 presented the lowest percentage of infected tissues with 14.5 and 7.3 
% respectively. The total weight gain used as additional criteria for selection showed that 
both 4638 and P42 were among the isolates with no significant differences against controls, 
along with 4607. For these reasons there was no further focus on these 2 isolates for the 
present work.  
 
Isolate F07-220 showed the highest overall relative frequency of viral detection in all tissues, 
as well as the relatively lowest weight gain. Isolate 4640 and 4607 had similar frequency of 
detection in the main 3 tissues (heart, skeletal muscle and brain), however 4640 was also 
detected in other 3 additional tissues (liver, spleen and pancreas) although in single 
individuals. 
 
Even though the actual target cell/cells for the virus has/have not yet been clearly identified 
(26), SPDV has been detected in all the tissues or organs examined and hence is been 
reported as a pantropic virus (13,27). More recently it was shown that it is also detectable in 




General viral screening by PCR for diagnostic purposes at the Marine Laboratory was 
traditionally done from kidney samples. Kidney had proven successful for detection of 
several other salmon viral agents of Atlantic salmon such as Infectious Pancreatic Necrosis 
virus (IPNV), Viral Haemorrhagic Septicaemia virus (VHSV), Infectious haematopoietic 
necrosis (IHN) and Infectious Salmon Anaemia virus (SAV) (29). For SPDV however, it was 
becoming recognised that the inclusion of heart tissue was relevant to improve detection, 
particularly during the chronic stages where RNA had been shown to persist in the heart for 
≥ 140 dpi (30). The results of this study, which examined a wider set of tissues for SPDV 
detection, further provided evidence to support the inclusion of heart when screening for 
SPDV, and a mix of kidney and heart tissues became the norm for diagnostic samples 
intended for SPDV at MSS (MSS internal protocols).  
 
In this study at 30 dpi all fish had at least one tissue with a positive SPDV detection. 
However, with 75% of samples positive across all isolates, the most efficient tissue for SPDV 
detection was the heart, with more than double the frequency of detection when compared 
with the next most efficient (skeletal muscle) followed by the brain. In this study the four 
other tissues examined showed hardly any detection. The results from heart, skeletal muscle 
and brain are in line with SPDV detection by virus isolation or PCR from previous reports, 
including although less frequently, that of the brain (13,31,32). Interestingly, in this 
comparison, although frequency of detection and Ct values from the brain were not high, in 
the case of two isolates (F07-220 and 4607) the viral RNA relative expression level to 
housekeeping gene (elf), showed instead more relevant than heart or skeletal muscle. Brain 
viral RNA signal was reported to remain detectable up to 190 dpi in a Norwegian tissue 
tropism experiment (13). Considering the role of the brain as target tissue in alphavirus 
infections of other vertebrate hosts (33), relevance during SPDV infection is a subject that 
deserves yet further investigation.  
 
Based on the current results two subtype 1 isolates (F07-220, 4640) were chosen for further 
work. Isolate 4607 also showed promising results with comparable frequencies of detection 
in the heart and skeletal muscle. In terms of weight gain however, it was the second best 
after the controls. As a subtype 2 isolate and associated with fresh water sleeping disease, 
4607 was considered less suitable also because work in this project was intended to 
continue specifically in Atlantic salmon.  
 
Incidentally, the choice for including 4640 was reinforced by additional information from an in 
vitro comparison exercise that was conducted contemporary at MSS. The in vitro cell culture 
comparison used TO cells (cell line originated from Atlantic salmon head kidney leucocytes) 
(34) and included all but one (F07-220) of the isolates used in the here reported in vivo work.  
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The study measured viral nsP1 gene expression relative to elf along 14 days and results 
highlighted the performance of isolate 4640 (summary figure from that study provided under 
Annex as Chapter 1, annex figure 1). Although the infectivity and/or virulence of viral isolates 
may differ between in vivo and in vitro work, the additional information of 4640 in vitro 
infectivity reinforced the decision for its inclusion.  
 
In regards to tissue sample for further studies, the heart, skeletal muscle and brain were 
chosen for further work. Although is not certain if the molecular signal represents a true 
carrier state, the results specially for the heart coincides with the organ being one of the 
most relevant during the disease with pathological changes characteristic of PD. The heart in 
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CHAPTER 3: EXPERIMENTAL COMPARISON OF 






The establishment of a cohabitation sea water infection model that mimics closely a natural 
infection on Atlantic salmon post smolts had been set as a requirement for the study of 
SPDV infection strategies in the first section of this PhD project. 
  
Experimental transmission of SPDV had been successfully achieved soon after the disease 
was recognised, initially by intraperitoneal (ip) injection of tissue homogenates (1,2) and later 
with purified virus (3–6). This challenge approach by ip infection has been extensively used 
to study the disease including aspects of host immune response.  
 
As it was found that SPDV can induce both Pancreas disease (PD) in Atlantic salmon 
(Salmo salar L.) as well as Sleeping disease (SD) in rainbow trout (Oncorhynchus mykiss) 
both in fresh and salt water, experimental infections have been frequently performed in fresh 
water using either fish hosts (7,8). In the case of Atlantic salmon, most experiments have 
used fresh water developmental stages: fry, parr or pre-smolt (4,6,9–11). Although an early 
report of successful transmission by co habitation (reported as “in contact” fish) using a 2:1 
ratio of ip to cohabitant (ch) fish in sea water Atlantic salmon post smolts was reported (3) 
fresh water challenges remained a very common choice. The approach kept being popular 
even in co-habitation challenge performed more recently, such as the comparison of several 
sea water origin isolates representing the different subtypes (12).  
 
This approach may have had a strong influence in the results of these studies, considering 
the profound adaptations of the fish’s endocrine, osmoregulatory, and immune system 
known to occur during the smoltification process preparing salmon for their sea water life 
(13,14). It is important to consider the influence that physiological, morphological and 
behavioural changes associated to smoltification could have on salmon susceptibility and 
response to SPDV infection. For example, substantial changes in immunocompetence, such 
as decreased levels of serum protein and IgM during the parr-smolt transformation (15) or 





Although currently the above has been fully recognised and recently, more complex models 
of bath immersion (BI) in sea water have been proposed (17), at the time this thesis project 
was being designed a co habitation sea water model had not been established at Marine 
Scotland Science (MSS). 
 
Teleost fish as other vertebrate hosts, present an innate, early line of defence against viral 
infections mediated by the interferon (IFN) system (18,19). Considered the most important 
component, type I interferon (IFN-I) is present and well developed in Atlantic salmon (20) 
and among the several  IFN stimulated genes (ISGs), mx in salmonids has been profusely 
studied and shown to be only one with relevant antiviral properties (21). They induce the Mx 
proteins, members of the dynamin superfamily of large GTPases responsible for rendering 
the antiviral state within the cell. 
 
Contemporary in vitro studies at MSS on the host response to SPDV of a novel genetically 
modified CHSE cell line over-expressing the Interferon (IFN) inducible mx gene, it was 
shown that the Irish type reference  F93-125  was more sensitive to the Mx protein than 
isolate 4640 (Marine Scotland Science isolate, originated on sea water salmon from 
Scotland) (22). Additionally, these two same isolates despite showing a 99.4 % similarity in 
amino acid sequences over 9 coding regions, were reported to elicit different kinetics of viral 
nsP1 and host mx genes expression (23), when infecting T0 cells, a line originated from 
Atlantic salmon head kidney leucocytes (24). While isolate F93-125 induced a fast and high 
level of viral gene expression leading to cytopathic effect, isolate 4640 induced low levels of 
viral gene expression and the culture did not show CPE. Additionally the  expression level of 
the mx gene was considerably higher in cells infected with isolate 4640 than with F93-125 
(23). All these suggest a fundamental difference in virulence strategy between highly similar 
SPDV 1 subtypes isolates, potentially involving IFN evasion mechanisms.  
 
An additional factor to consider for results interpretation is the previously mentioned potential 
of cell culture adaptation (see Chapter 1). Similarly as with viral pathogen in other hosts, a 
low passage number of laboratory cultures to be used for in vivo infections is important to 
avoid or reduce the potential attenuation due culture adaptation, Such situation had been 
already suggested for SPDV (25,26) where isolate F93-125 had been  reported to have lost 
virulence in vivo, potentially as the results of this culture induced adaptation (6). 
 
The previous work had pointed to isolate 4640 as one of the more appropriate candidates for 





• Establish a working sea water challenge model by cohabitation  
• Apply the model to compare in vivo putative intra subtype infectivity differences 
between F93-125 and 4640  
• Identify viral tropism patterns during the course of infection (by quantitative RT-PCR) 
• Evaluate viral nSP1 and host mx genes expression along time. 
 
 
Hypothesis: the dynamics of infection of two SPDV-1 isolates on Atlantic salmon smolts in a 
sea water, can be examined through a longitudinal time course experiment after natural 
infection by cohabitation  
 
 
By challenging Atlantic salmon post smolts through a cohabitation model in sea water, this 
section of the work aimed to assess the kinetics of infection of two SPDV 1 isolates in sea 
water post smolts. Previous in vitro information of the two isolates supports comparison of 
intra subtype differences, using the kinetics of the viral expression and host mx response 
and evaluating the putative loss of in vivo infectivity of F93-125. Additionally, a virus 
distribution among three tissues (heart, brain and skeletal muscle) over 8 weeks post 
infection could be examined.  
 
As the current experiment was to go ahead, unexpectedly the aquarium facility at MSS 
became unavailable. To compensate for this, a bid for external funding was developed 
through the Network of Animal Disease Infectiology Research (NADIR). The successful bid 
made funds available to take it to VESO-VIKAN in Namsos (Norway), finally allowing for the 
experiment here reported to be completed.  
 
 
Materials and methods 
 
Unvaccinated Atlantic salmon smolts (390) with an average weight of 160 g ± 10 g were 
obtained from a single source. A sub sample (n=30) was pre-screened by RT-qPCR to 
check viral free status from SPDV, and other prevalent infections such as Infectious 
Pancreatic Necrosis virus (IPNV), Piscine myocarditis virus (CMSV) and Piscine Reovirus 
(PRV). Fish were acclimatized to seawater at 14° C for 2 weeks prior to the challenge. They 
were randomly distributed into groups of 72 fish into 5 separate 1 m diameter, 500 L tanks. 
Four tanks were allocated to “treatment“ (replicates per SPDV isolate) and one to “control”. 
Water flow was maintained at 10.8 l/min and oxygen saturation at 70%. The rate of (ip) 




From each tank, forty fish were anaesthetised in a solution of tricaine methanesulphonate 
(MS222 Sigma, Irvine, UK) at a dose of 80 mg/L. Each fish had its adipose fin clipped using 
a VESO approved protocol for individual fish identification.  
The virus isolates had been propagated at the MSS laboratory using Chinook salmon 
(Oncorhynchus tshawytscha) embryo cells (CHSE-214, ATCC CRL 1681) for 7 days (4), 
they were titrated in the same cell line and material sent frozen to VESO. Prior to the 
challenge, virus stock was thawed at room temperature and doses prepared. Shedder fish 
from replicate treatment tanks were ip injected with 200 µl at 6.25 x105 TCID50 for isolate 
4640, and at 6 × 105 TCID50 of isolate F93-125. Control tank shedder fish were ip injected 
with 200 µl of uninfected tissue culture media (CHSE-214). Shedders were then released 
back to the tank, which they shared with thirty-two ch fish, where they fully recovered from 
anaesthesia within minutes. Water flow was reduced to 200 l/h (approximately 1/3) between 
days 5-10 post shedder infection. The experiment was run for 61 days post shedder 
infection. Fish were fed to appetite throughout, although food was withdrawn 12–24 h before 
handling for sampling. 
 
Sequential sampling points of ch fish were pre-established for 5, 8, 12, 16, 21, 30, 44 and 61 
days post shedder infection (dpi). At each time point an overdose of anaesthesia (MS222 as 
above) was used to euthanize a sample of 4 ch fish (identified by the absence of fin clipping) 
per tank, adding to a total of 20 fish per time point (8 per treatment and 4 controls). All fish 
were weighed and had a blood sample of ~2-4 ml taken through caudal vein puncture into 
vacutainers tubes containing sodium citrate (Greiner). These blood samples were taken for a 
collaborative contemporary project carried out by colleagues of the MSS research group. 
The work intended to develop and validate a method to measure viraemia indirectly using an 
Atlantic salmon reporter cell line. For RT-PCR, small portions of skeletal muscle (SM), heart 
(H), and brain (B) were collected into RNA later. At the termination of the experiment all 
remaining fish (ip shedders) were euthanized by terminal anaesthesia, and blood and heart 
tissue samples collected from 10 such fish from each treatment tank.  
The viral load was measured as transcription of the nsP1 gene and host response as 
expression of the mx gene, normalized against elongation factor (elf α) following the same 
procedures as described in chapter 1, but using duplicates instead of triplicates for the 
quantitative RT-PCR. Expression of mx from control fish was only performed in the heart 
samples. For quantitative assessment of the gene expression, delta Cts relative to elf was 
used.  The weight average of all fish sampled per group (treatments and control) was 
calculated at each time point, and total weight gain per isolate was calculated as the 
difference between the average weights at the last time point relative to the average weight 







No mortality was recorded among ch fish or any of the control fish during the length of the 
experiment. Only two individuals from each replicate tank of isolate 4640 were found dead 
on days 27 and 33 post infection, corresponding to ip (shedder) fish. 
 
Isolate F93-125 failed to establish a measurable infection on the ch fish with no detection in 
any of the three tissues analysed along the 8 sampling time points. Results from ip fish at 
terminal sampling showed none of the F93-125 ip injected fish were positive after 61 dpi.  
 
Isolate 4640 was successfully transmitted to ch fish. The first positive signal was recorded at 
12 dpi in 2/8 fish in the heart and brain tissues. The peak of detection was at 30 dpi when 8/8 
heart samples, 5/8 brain samples and 6/8 skeletal muscle samples tested positive. The peak 
was followed by a decrease by day 44 with 4/4 detection only on the heart and brain and by 
day 61 detection in heart decreased to 3/8 while skeletal muscle showed 5/8 positive fish 
(Fig. 1).  
 
 
 Fig. 1: Isolate 4640 nsP-1 viral signal per tissues and time point. H=heart, B=brain, SM= skeletal 
muscle. 
 
The viral nsP-1 and mx expression levels relative to housekeeping gene elf are shown by 
tissue in figures 2-4. Briefly, in the heart viral ns-P1 signal was first detected at 12 dpi and 
peaked by day 16, coinciding with the strongest expression of mx (Fig. 2). From that point 
viral signal decreased reaching lower levels than initial signal at day 12, by 61 dpi. The mx 
expression, particularly from infected fish only (purple curve in graphic), followed a similar 





























Fig. 2: Kinetics of viral nsP1 and mx gene expressions of heart (H) tissue of Atlantic salmon post 
smolts, after experimental infection with SPDV subtype 1 (4640) by  co habitation. The mx expression 
of infected fish only is indicated in purple. Vertical bars indicate standard deviation, sample size = 8 fish 
per time point. 
 
Brain viral ns-P1 signal was first detected at 12 dpi, increasing by 16 dpi but describing a 
sharp decline by 21 dpi. After that the peak expression on this tissue was recorded by 30 
dpi, declining thereafter. The mx expression showed a slow steady increase from 5 dpi on 
and peaking by 30 dpi. Note that when only viral infected fish are considered (purple line) the 
peak was recorded instead at 16 dpi. By 44 dpi viral and mx genes expression started to 
decline and continued so until terminal sampling. The infected fish only showed a decline at 
44 dpi but increased again by 61 dpi terminal sampling.   
 
Fig. 3: Kinetics of viral ns-P1 and mx gene expression of brain (B) tissue of Atlantic salmon post 
smolts, after experimental infection with SPDV subtype 1 (4640) by co habitation. The mx expression 
of infected fish only is indicated in purple. Vertical bars indicate standard deviation, sample size = 8 fish 
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The skeletal muscle viral signal was detected only at 3 time points and started with its peak 
expression at 16 dpi, declining thereafter. The mx response peaked at 12 dpi and sharply 
decline by 16 dpi. Signal detection returned to peak level by 21 dpi and decreasing thereafter 
without reaching the low levels from 5 and 8 dpi. Note infected fish only (purple line) 
described the peak expression at 16 dpi in coincidence with viral signal.   
 
Fig. 4: Kinetics of viral nsP1 and mx gene expression of skeletal muscle tissue of Atlantic salmon post 
smolts, after experimental infection with SPDV subtype 1 (4640)  by co habitation. Vertical bars 
indicate standard deviation, sample size = 8 fish per time point. 
 
No viral RNA signal in F93-125 ch fish was detected, however the heart mx gene expression 
after a steady decline along the 6 first time points showed a mild relative increase by 44 dpi, 
ending higher than controls fish by terminal sampling point (Fig. 5).   
 
 
Fig. 5: Kinetics of mx gene expression of heart (H) tissue of Atlantic salmon post smolts, after 
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The average weight per group at each time point showed both infected groups lagged 
behind control fish the differentiation starting from 21 dpi on (Fig. 6).  
 
 
Fig. 6: co-habitant fish average weight by sampling time point. 
 
Weight gain of ch fish challenged with isolate F93-125 was 59.2% that of control ch fish 
while ch fish challenged with isolate 4640 showed the lowest weight gain, reaching only 
23.9% of that from controls and 41% of the gain by isolate F93-125 (Fig. 7).  
 
 
Fig. 7: Cumulative weight gain by co habitant fish on treatments and controls groups. 
 
At terminal sampling of isolate 4640 ip fish, from only 3/20 heart tissue samples showed a 
















































The current experimental infection aimed to explore potential SPDV intra-subtype differences 
in vivo, by comparing two SPDV-1 isolates with reported in vitro differential performance in 
terms of infectivity. To mimic as close as possible natural infection in sea water at the 
developmental stage more vulnerable to the disease (17), the experimental setting aimed to 
achieve transmission by co habitation using salmon post smolts.  
 
The reasons behind the very variable mortality and pathology observed after SPDV infection, 
both at the farm level and experimentally, are not fully understood but suggestions include 
the single or combined effect of co-infections, environmental factors and potential differences 
among subtypes (12,27).  
 
Based on sequencing data of SPDV isolates collected over a 20 years period from marine 
farmed Atlantic salmon (28), analysis of the geographical distribution of SPDV showed that 
subtypes 1, 2, 4 and 5 can be found in Scotland. However, consistent clusters of a more 
dominant subtype were also shown to exist, such as subtype 1 in the region of Argyll and 
Bute or subtype 2 in the Shetland and Orkney islands. Albeit only descriptive, observations 
from field cases arriving at the MSS diagnostic laboratory pointed as well to considerable 
variations in the mortality, clinical presentation and pathological changes between cases 
associated with isolates belonging to the same subtype (personal observations, MSS 
diagnostic internal reports). Observed variations of the clinical and pathological presentation 
can be related to several other factors as previously suggested, as well as confounding 
effects of the disease stage at the sampling time. However, the observations also suggest 
intra-subtype or isolate-related variation. 
 
Differences in the dynamics of infection between subtypes have been observed during the 
comparison of isolates originated in marine cases representing all 6 subtypes (12). In their 
experimental infection by co-habitation in fresh water, transmission was achieved with all 
isolates. However, there were differences in transmission efficiency and pathological, 
serological and virological levels were also highly variable. For instance, subtypes 1 and 3 
had consistently higher virus loads and associated pathology, coinciding with a synchronous 
ch fish infection and differentiating these two subtypes from the performance of subtypes 2 
and 6. 
 
In the current experiment isolate F93-125 showed no detectable viral signal at any tissue 
along the 8 weeks of the experiment, this is in agreement with previously suggested 
infectivity attenuation of the isolate (6,25). The heart mx gene expression for F93-125 
showed a slight increase relative to controls by terminal sampling (Fig. 5), the average 
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weight gain was intermediate between the controls and isolate 4640 (Fig. 6) and the 
cumulative weight gain showed to be ~40% lower to that of controls (Fig. 7). Altogether, this 
seems to indicate that while not detectable with the here applied approach, there could have 
been a mild effect of F93-125.  
 
Results from previous Norwegian work on tissue tropism of different SPDV subtypes 
concluded in a similar hypothesis after using F93-125 as a representative of SPDV subtype 
1 (26). Isolate F93-125 as the founder of subtype 1 (original PD case reported) (29) had 
been widely used for experimental infections until the suggested loss of virulence started to 
be reported. In the Norwegian experiment, no clinical signs or macroscopic lesions were 
observed but 40% from a total of 303 samples from 7 different tissues were positive for the 
virus by RT-PCR. The highest RNA loads and percentage of positive samples was observed 
within 7 dpi, however, the F93-125 viral loads were ~ 5000 folds lower than those from fish 
inoculated with the subtype 3 being compared (derived from infectious tissue homogenates). 
The authors’ conclusion was that while F93-125 may have still be infectious, a culture 
adaptation process (or an adaptation to British salmon strains) could be behind the lower 
viral loads and a faster clearance by host immune response noted for the isolate (26).  
 
The current experiment achieved the goal of cohabitation transmission with isolate 4640, 
with viral detection starting in one or more fish and tissues at 12 dpi and remaining 
detectable until the end of the experiment 61 dpi. Detection peaked at 30 dpi with all three 
examined tissues positive and the heart and the brain samples remaining positive by 61 dpi. 
No mortality was recorded but average weight among ch fish lagged behind control and of 
isolate F93-125 (Fig. 6), the total cumulative weight gain relative to controls was only ~24% 
(Fig. 7).  
  
In the current experiment the kinetics of expression of the mx gene described a good 
alignment with the viral signal, particularly in the heart tissue (Fig. 2), followed by the brain 
(Fig. 3). From 12 dpi and until 44 dpi the heart mx expression was at all times higher relative 
to controls, which coincide with the increased on viral signal peaking by 16 dpi. When viral 
signal decreased to levels below those of the initial detection, the mx expression decreased 
too (44 dpi) and continued decreasing to reach control levels by 61 dpi. The brain tissue 
kinetics followed a similar pattern although viral signal was initially detected and peak with a 
week delay. For the skeletal muscle the signal of viral and mx gene expressions were not as 
neat, most likely related to the low number of positive fish. Particularly, the signal for the 
virus was fragmented but still showed a response of mx that remained induced even when 




Interferon stimulated genes (ISGs) are essential for host antiviral defence and among them, 
mx is the most widely studied in teleost fish (30). Differences in the expression pattern(s) of 
the mx gene induction have extensively been used to assess host response during viral 
infections of fish, including Atlantic salmon (31,32). For comprehensive reviews on the 
subject see (20,30,33,34). 
 
In all three tissues examined in this experiment, when the average mx expression of infected 
fish only (purple line in figures 2-4) was outlined, it showed always to be higher than the all 
fish average. This is not surprising and suggests that although mx induction becomes 
systemically detectable (as shown with these same set of samples when blood was tested 
(35)) the individual contributions of the specific infected tissues are clearly important. In this 
sense it highlighted the mistake of the current experimental design when choosing to 
measure from control fish only the heart mx rather than from all three tissues examined.  
 
In principle, this in vivo comparison seemed not to align with previously reported in vitro 
results (23). However, it is to notice that host response to isolate 4640 at the heart tissue (as 
mx expression therefore the same parameter used for the in vitro work), may have 
comparatively managed to successfully restrict virus replication within the period analysed 
(Fig. 2), and mx levels returned to normal by the end of the experiment. In that way results 
are a similar outcome to what occurred in vitro, however in a much-extended time period of 8 
weeks. The 4640 ip fish results indicating the virus had been cleared, would possible reflect 
the host response capacity suggesting that, although isolate 4640 can clearly infect and 
replicate for transmission to occur, it can also be cleared by the host within a period of 8 
weeks.  
  
As a parallel useful outcome of this experiment, the blood samples collected from isolate 
4640 were used for a contemporary project that examined the capacity of a reporter cell line 
to detect viral infection. This resulted in the proof of concept of the successful detection of 
viraemia by monitoring blood from infected fish (35), with comparable results to those 
obtained with the here reported data from tissues. The parallel project resulted in a 
publication in the Journal of Virological Methods 191 (2013) 113– 117 (provided under 
Annex, Chapter 2, paper 1).  
 
SPDV has unfortunately been around the aquaculture industry for decades; however, lots 
have been learnt since the early reports of the disease. Experimental models have 
experienced an important refinement and although ip and cohabitation models would remain 
as useful tools, since the work here reported was performed other very interesting and more 
complex approaches have been developed, such as the recently proposed infection by bath 
immersion used to demonstrate the differential susceptibility of smolts depending of time 
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after transfer to sea water (36) . This later approach where the exposure time and control of 
the viral dose can be accurately estimated would likely be the way forward to further 
exploring in vivo the remaining challenges SPDV impose to the sustainable growth of the 
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The content of the following chapter is presented in the form of a published paper: Atlantic 
salmon cardiac primary cultures: An in vitro model to study viral host pathogen interactions 
and pathogenesis, Patricia A. Noguera, Bianka Grunow, Matthias Klinger, Katherine Lester, 
Bertrand Collet, Jorge del-Pozo. PLOS ONE 2017, Vol:12 (7) pp:22. 
 






Atlantic salmon (Salmo salar) production has increased in the past 30 years to become the 
world’s largest by volume among salmonids. Inevitably, as any other intensively farmed 
species, infectious diseases in aquaculture are a major constraint to the industry and salmon  
is vulnerable to several viral agents that target the heart tissue, such as those induced by 
Salmon Pancreas Disease Virus (SPDV).   
 
In order to help support the development of disease control and management strategies, the 
knowledge gaps identified by the industry and research communities were at the centre of 
this thesis project. One of such gaps was the improvement of experimental models for the 
study of transmission and disease mechanisms in SPDV infections.  
 
In spite of a pantropic tissue distribution (1) infections by SPDV have three main target 
tissues recognised as most severely affected, e.g. the pancreas, the skeletal muscle and the 
heart  (2), tissues traditionally examined for diagnosis by histopathology. Viral screening by 
molecular approaches (PCR) has shown the relevance of the heart tissue for detection and 
similarly, observed during the previous in vivo work of this thesis (chapters 1 and 2).  
Understanding the basis of cardiac diseases in fish is limited by the lack of models that 
would better reflect the complexity of the heart (3). Research in fish disease seems to lag 
behind with approaches and technologies applied long used in veterinary and human 
medicine, such as cellular models.  Interestingly, fish has become a widely used model for 
applied research on non-piscine species. This includes the development self-contracting 
cardiomyocyte aggregates isolated from rainbow trout and intended for human’s drug 
pharmacological testing (4,5). It was the awareness of that type of approach that triggered 
the interest in adapting and establishing a model based on the species of interest –Atlantic 
salmon- and to evaluate their potential as an in vitro model specifically intended for fish 
disease research. 
The content of this section presented as paper 1 represents my own work where I was 
responsible of the conceptualization, performing the experimental work, data curation, formal 
analysis, writing the original draft, collecting co-authors feedback, review and final editing. 
Paper co-author’s specific contributions are fully acknowledged and details accessible 











































































It was possible to isolate cardiac primary cultures originated from salmon embryos which 
were viable in culture for several months. By characterizing the production efficiency factors 
reported on paper 1 it was possible to establish a system to generate sufficient SCPCs 
numbers to allow for experimental work.  
 
From the two morphologies the heart cultures developed, the ex vivo type, is likely the one 
with more potential for future work as it essentially represents the embryonic heart further 
maintained in culture and therefore, the closest to the heart as a functional organ.  
 
Further work will be required to address important aspects with potential impact on the 
application of the model, such as the effect of aging during culture. Additionally, a thorough 
characterization through immunohistochemistry would be ideal and something missing 
during the current work.  
 
The SCPCs model was challenged with different SPDV isolates and the viral load and the 
mx gene expression were measurable along time by qPCR. Applying the model to study 
other relevant viral cardio tropic agents such as Piscine reovirus (PRV, inducing Heart and 
Skeletal Muscle Inflammation) and Piscine myocarditis virus (PMCV, responsible for 
Cardiomyopathy Syndrome) would be ideal to further assess the model’s suitability. The 
limitation for this has been the difficulty to obtain purified PRV and PMCV isolates. 
  
The SCPCs model represents a step forward in salmon cardiac disease research as an in 
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The content of the following chapter is presented in the form of a published paper: Use of 
Salmon Cardiac Primary Cultures (SCPCs) of different genotypes for comparative kinetics of 
mx expression, viral load and ultrastructure pathology, after infection with Salmon Pancreas 
Disease Virus (SPDV), Patricia Noguera, Bertrand Collet, Matthias Klinger, Hristo Örün, 






Cellular in vitro models are long standing tools for medical and veterinary research. They  
include some based on fish species, primarily the zebra fish (Danio rerio) (1–3), but also 
others such as guppies (Poecilia reticulate) and rainbow trout (Oncorhynchus mykiss)  (4–6) 
and extensively used in morphological studies, cellular and molecular processes, 
regenerative biology and pharmacological testing. Unfortunately, not many models based on 
fish are meant specifically to study fish issues (e.g. diseases, pathogen virulence and 
pathogenesis or cell tropisms).   
 
During the work presented in chapter 3 to establish the Salmon Cardiac Primary cultures 
(SCPCs) as a study model, the question soon emerged as to whether the genetic 
background (egg origin) of the embryos used to produce SCPCs, could influence the 
outcomes after infection: does the embryo genetic trait manifests at the SCPCs model? 
 
Using commercially available eggs (AquaGen® Norway) of two different genotypes (Atlantic 
Ova IPN sensitive” and Atlantic QTL-innOva® IPN/PD), the content of paper 2 here 
presented as chapter 4 was developed with the goal to respond to that question. The viral 
load, a component of the host immune response (mx expression) and the ultrastructure 
pathology were used for comparison. 
 
The content of this section represents my own work having been responsible of the 
conceptualization, performing the experimental work, data curation, formal analysis, writing 
the original draft, collecting co-author’s feedback, review and final editing. Paper co-author’s 
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Using SCPCs produced from two commercially available Atlantic salmon embryonated ova 
of different genotypes, the potential influence on the outcomes of infection with Salmon 
Pancreas Disease Virus (SPDV) was assessed.  
 
Results showed that while both genotypes SCPCs got infected, a measurable difference 
could be observed in the kinetics of viral and mx gene expressions. The ultrastructural 
examination by transmission electron microscopy (TEM) allowed the description of 
degenerative changes associated with the infection at individual cell level, however they 
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CHAPTER 6: ULTRASTRUCTURAL INSIGHTS 
INTO THE REPLICATION CYCLE OF SPDV USING 
SCPCS 
 
Note: the current chapter was prepared and written as a paper although it had not been 




The genus Alphavirus (Togaviridae) is a diverse group of viruses recorded worldwide from a 
wide range of invertebrate and vertebrate hosts [1]. Alphavirus are predominantly 
arboviruses (transmitted by arthropod vectors), with mosquito species being the most 
common invertebrate host, along with ticks, biting fly and lice [2,3]. Vertebrate hosts include 
humans and nonhuman primates, equines, pigs, rodents, birds, reptiles, amphibians and 
fish. The majority of alphaviruses are capable of replicating in a range of insect and 
vertebrate cell lines  [4]. 
 
Alphaviruses are small, enveloped viruses with a single copy of positive-stranded genomic 
RNA. The mature alphaviral particle has an icosahedral morphology of ~70 nm in diameter 
[5]. The genomic material is encased in an icosahedral nucleocapsid (NC), which in turn is 
enclosed within a lipid bilayer (envelope) where glycoproteins are inserted [6]. The envelope 
glycoproteins form an icosahedrally ordered shell or scaffold that surrounds the viral 
membrane [7] , with its surface bearing characteristic trimeric spikes [5,8].  
 
Several members of the genus Alphavirus are responsible for a wide range of debilitating 
conditions in humans and animals [3] . Salmon Pancreas Disease Virus (SPDV), also 
referred to as Salmonid Alphavirus (SAV), is the first member of the group isolated from a 
fish species and an exception in the genus in that it does not require an arthropod vector [9–
12]. SPDV has been reported for over 3 decades in salmonids (Atlantic salmon Salmo salar, 
rainbow trout Oncorhynchus mykiss, and brown trout Salmo trutta) [13–15], and recently in 
some non-salmonid marine species such as the common dab (Limanda limanda), which may 
act as a wild reservoir [16–18]. The relatively more restricted host range of SPDV compared 
to that of terrestrial alphaviruses suggests temperature sensitivity is likely to play a role in 




SPDV is associated with two diseases affecting the salmonid farming industry [10,20]. 
Pancreas disease (PD) of Atlantic salmon was first recognised in 1976 and described by 
1984 [21]. A similar condition in rainbow trout was reported initially in France in 1994 and 
was named Sleeping Disease (SD) [22]. The confirmation of their viral aetiology and 
evidence of being the same agent (SPDV) followed soon after the first reports of both 
diseases [11,20]. 
 
At present  SPDV is divided into 6 groups, referred to as “subtypes”, based on analysis of 
the viral sequence [23]. Subtypes 1 and 2 are the most commonly found in all affected SPDV 
regions. Subtype 2 presents two forms, a freshwater one responsible for SD in the UK and 
continental Europe, and a sea water one which has been recorded in Scotland and more 
recently, in Norway [24–26]. Some subtypes show a more restricted geographical 
distribution, as subtype-3 recorded only in Norway and subtype-5 in Scotland [25,27].  
 
SPDV has been detected in heart and skeletal muscle, pancreas, pseudobranch, gills, brain, 
liver, spleen, head kidney leukocytes and transiently, the serum [28–33].  
 
Mortality rates vary widely between SPDV outbreaks, infected animals may experience 
chronic loss of appetite with consequent weight loss. Additionally, a proportion of the 
survivors never recuperate and remain extremely thin (“runts”), rendering them  unsuitable 
for the market [13]. This is partly similar to many mammalian alphaviral infections that 
present a low mortality rate (Chikungunya, Venezuelan, Western, and Eastern equine 
encephalitis viruses (CHYKV, VEEV, WEEV, and EEEV, respectively), however the 
associated disease conditions can have long term sequelae [34,35]. 
 
Direct horizontal transmission of SPDV is well documented (see review by Atkins) [36], 
demonstrating that an arthropod vector is not mandatory for its spread. However, given all 
other alphavirus are arboviruses and because Atlantic salmon is highly susceptible to 
infections by the sea louse Lepeophtheirus salmonis, the possibility of a role of of the 
parasite on SPDV transmission has been investigated. Despite positive RT–PCR detection 
in the lice, there was no proof of replication of the virus in that host [37], therefore, any 
potential involvement of sea lice remains conjectural. 
 
Due to their pathogenic nature, several alphaviruses have been widely studied. Particularly 
the type reference Sindvis (SINV), the Semliki-Forst virus (SFV), the aforementioned VEEV, 
the Ross River virus (RRV) and recently the CHYKV species [5,38]. The advances achieved 
in the wider field of alphavirus research provide a profuse source for comparative analysis of 
the relatively newer and less studied SPDV, where several knowledge gaps are still 
recognised [13,25].  
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Recently, the morphogenesis of SPDV in vitro (as well as aspects of the pathogenesis in 
vivo have been reported by ultrastructural examination (in CHSE-214 cell line and Atlantic 
salmon parr, respectively) [33,39]. These studies showed some of the events after viral 
internalization, including endosome formation, features related to cytoplasmic replication, 
presence of spherules and virus budding at the plasma membrane. However, when 
compared to any other member of the genus Alphavirus, there is still a marked scarcity of 
further insights into the replication cycle of SPDV.  
 
With the salmon heart being one of the most relevant affected organs during SPDV in vivo 
infections, the current work aimed to contribute to the understanding of the virus replication 
cycle using a salmon cardiac primary culture model [91,92]. The ultrastructure morphology of 
features observed from 2 up to 72 hpi are described and discussed by comparison with 




Material and Methods 
 
Commercially available embryonated Atlantic salmon eggs were obtained from AquaGen® 
and  SCPCs generated  following protocols previously described [40]. In brief, embryos were 
swiftly removed from the shell, mechanically and enzymatically disaggregated, tissues 
centrifuged in culture media and the final pellet re-suspended in fresh media for plating. 
Incubation was performed at room temperature and relevant tissue harvested from 24hs 
onwards, transferred as individual cultures into x8 well chambered glass slides (Nunc® Lab-
Tek II, Thermo-Fisher-USA) for further incubation. SCPCs were maintained with 0.5 ml 
culture medium (L15, Lonza, UK) supplemented with 10 % foetal bovine serum (Sigma-
Aldrich, USA), 100 U/ml Penicillin and 0.1 mg/ml Streptomycin (Fisher Scientific, UK)). 
 
Infection was performed in situ at a dose of 2.4x104 plaque forming units (PFU)/ml, using a 
virulent SPDV subtype -1 isolate that originated from an outbreak in Ireland ( F07-220 
provided in kind by Dr David Graham, formerly at Agri-Food and Bioscience Institute, 
Belfast). After absorption at 15ºC for 2h, the infected culture medium was exchanged for 
fresh medium and similarly, culture media was exchange on control wells with non-infected 
SCPCs. Incubation continued at 15ºC and two to four infected SCPCs were sampled at 2, 3, 
24, 48 and 72 hours post incubation (hpi), i.e. from end of absorption time and culture media 
exchange.  
 
For transmission electron microscopy (TEM) SCPCs were fixed in situ by adding 0.5 ml cold 
Karnovsky’s fixative (2.5% glutaraldehyde and 2% paraformaldehyde in 0.1 M phosphate 
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buffer pH 7.4) to each well and left for 30 min at room temperature. Fixed SCPCs were 
transferred to a 1.5 ml Eppendorf tube with 0.1 M Phosphate buffer saline pH 7.4 (PBS) and 
washed for 15 min on a rotator disk. This procedure was repeated twice, followed by transfer 
to fresh buffer for short-term storage at 4°C. For post fixation, 1% OsO4 in 0.1 M Cacodylate 
buffer was applied for 2 h at 4°C followed by dehydration using a graded series of ethanol. 
Samples were then embedded in araldite resin (Fluka, Switzerland) and ultrathin sections cut 
on an Ultracut E (LEICA, Germany). Samples from time points 2, 3 and 24 hpi were 
processed separately and the 48 and 72 hpi were pooled as a single sample for processing. 
Staining was performed with 0.5% uranyl acetate (Laurylab, France) and 3% lead citrate 
(Laurylab) in an Ultrastainer AC20 (LEICA, Germany). Examination was conducted in a 
JEOL electron microscope JEM 1011 at 60 kV or JEM-1400 Plus at 120kV (JEOL, Japan) 
and all morphological descriptions here presented correspond to observations on infected 





Ultrastructural examination confirmed the permissiveness of SCPCs to SPDV-1 infection and 
replication, with viral particles noted within cardiomyocytes, endothelial cells, fibroblasts and 
intraluminal leukocytes. Several features of the viral replication cycle were observed, 
primarily in the first two cell types. 
 
At 2 and 3 hpi, the virus was seen undergoing internalization process or had already been 
internalized, with abundant endosomes and trafficking-like vesicles containing viral particles 
observed in the cytoplasm. Viral particles were observed in the proximity of the plasma 
membrane (PM) or attached to it. Two morphological types of internalization processes were 
apparent by TEM ultrastructure examination. A suspected clathrin-independent entrance 
which possibly involves attachment through an electron dense cloud between the viral 
particle and the PM (Figs 1 A) and internalization by an invagination of an electron-dense 
area of the cell surface resembling caveolae, (Fig 1 A, B), and internalization through the 
more widely accepted clathrin-mediated endocytosis (CCP), with formation of invaginations 
bearing a sub-membranous, spiky electron-dense band (Fig 1 C, D). In samples after 24 hpi 
both viral attachment and internalization by both apparent processes were still present. (Fig 
6 A, B).  
 
Internalization resulted in cytoplasmic membrane-bound vesicles containing viral particles 
consistent with endosomes (Fig 1 E). Free viral particles were also present in the cytoplasm 
(Fig 1 F) possibly after release from the endosome (Fig 1F insert). Virus-containing vesicles 
of different morphology were observed, occasionally within the same cell. These were 
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consistent with early (EE) and late (LE) endosomes (Fig 2). An electron-dense layer was 
noted lining early endosome membranes (Fig 2 A, C). To note was a tubular or neck 
structure observed connecting a pit coated vesicle to larger endosome-like compartment, 
containing  
 
multiple intact virus-like particles (Fig 2 B). Internalised vesicles with single viral particles 
within larger endosome were also seen releasing their content (Fig 2 C), with the particles 
detaching from membrane in a similar manner as that described for cytoplasmic particle 
release (Fig 1 F, insert). Large vesicles consistent with LE containing numerous, densely 
packed, viral particles admixed with loose debris, were observed as early as 3 hpi (Fig 2 D).  
 
Formation of spherules was observed at 3 hpi. These  characteristically bulb-shaped 
convoluted invaginations, have been previously described in the replication cycle of 
alphavirus [41,42]. In our study, these were seen on the PM and within cytoplasmic vacuoles 
(Fig 3 A, B, C, D). These spherule-containing vacuoles were morphologically consistent with 
previously described type I cytopathic vacuoles (CPV-I). In our study, CPV-I were ≥ 200 nm 
in diameter, frequently located in the peri-nuclear region and in the proximity of the RER (Fig 
3 E), and occasionally contained ~50 nm diameter, electron dense particles within (Fig 3 F). 
Additionally, spherule containing vacuoles occasionally had a prominent neck-like structure 
(Fig 3 C, D).  
 
Characteristic type II cytoplasmic vacuoles (CPV-II), as those described for other alphavirus 
in vertebrate hosts, were not observed in this experiment, but cytoplasmic structures with 
features similar to CPV-II as more recently described for SINV in vitro infected mammalian 
cell (baby hamster kidney BHK-15 [42] were observed from 24 hpi onwards. They are seen 
as pleomorphic, round to ovoid structure with a darker periphery due its surface being 
covered by evenly distributed, ~25-30 nm electron dense particles (Fig. 4). The centre of 
these structures could either be mildly to highly electron dense, and individual electron 
dense particles were visible in some of them (Fig 4 B).  
 
Viral budding at the PM was seen occasionally in samples over 48 hpi (Fig 5 A, B). 
Additionally, features resembling intra-cytoplasmic budding were seen (Fig 5 C, D). Extra or 
intracellular budding seemed associated with presence of electron dense sections of the 
plasma membrane and occasionally with e loos continuity (fragmented membrane) (Fig 5 A, 
C, D). 
 
Two additional relevant features in infected SCPCs were observed. One consisted of 
cytoplasmic moderate electron dense, loosely organised granular aggregates, consistent 
with previously described ribo-nucleoprotein stress granules (SG) [43] (Fig 6 C and D) which  
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were always associated with viral like particles in the vicinity displaying a regular spiky 
surface (Fig 6 B,C and D). The second observation were the filopoid extensions of the PM, 
also frequent after 24 hpi, particularly on endothelial cells and in intraluminal leukocytes (Fig 
6 E, F and insert). 
 
Signs of mild to moderate degenerative changes associated with the infection were recorded 
from 24 hpi, they included mitochondrial swelling, loss of cristae, multiple-membrane 
vesicles, myelin figures, peroxisomes, nuclear apoptosis and cell detachment. These 





Understanding replication cycle events and the underlying mechanisms used by successful 
viral pathogens is of great importance for the studies of host–virus interactions, and a 
requirement for the development and implementation of preventive measures such as 
vaccines and other targeted therapeutic strategies [45,46].  
 
Biological in vitro experiments are often performed based on immortalized cell lines and 
several cell lines of fish origin have shown to be permissive to SPDV infection [19,47]. The 
value of the use of continuous cell lines versus primary cells remains debatable, as a 
compromise weighing the practicality of using a readily available tool (which may differ from 
the in vivo behaviour in important aspects), against the benefit ascribed to primary cells of 
having relatively higher biological relevance [48]. Indeed, care is required in interpreting 
results from the use of continuous cell lines as they do not always replicate accurately the 
same events noted in primary cell lines [49]. Further, the continuous serial passages 
required for cell line maintenance have been reported to cause genotypic and phenotypic 
variations [48]. The current work uses salmon cardiac primary cultures developed from 
Atlantic salmon embryos, representing one of the SPDV targeted organs on the most 
relevant affected host species.   
 
Different alphaviruses such as CHIKV, SINV and SFV have been used to describe the viral 
replication cycle in affected vertebrates and invertebrate hosts. As zoonotic viruses, they 
have been the focus of extensive studies and several characteristics have shown to be 
shared among them. However, overall aspects of the traffic and assembly of viral 
components and the exit of the virions from host cells are yet not fully understood [50]. 
Moreover, given the variety of virus and host species, some mechanisms and a level of 
temporal or spatial variation among alphavirus virus species or between vertebrate and in 
invertebrate hosts, is to be expected. Recently for example, differences between SINV 
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infected mammalian and insect cell lines (baby hamster kidney BHK-15 and mosquito Aedes 
albopictus C6/36 respectively) have been described [42]. 
 
Features of SPDV replication cycle and infection at the ultrastructure level have been 
previously described through studies on the morphogenesis in vitro using Chinook salmon 
embryo cells (CHSE-214) and the pathogenesis in vivo, using Atlantic salmon juveniles in 
fresh water [33,39]. These studies used two Irish subtype-1 isolates, the type reference F93-
125 suggested to be culture adapted [15,30] for the in vitro work, and isolate F02-143 
originated from a 2002 outbreak for the in vivo work [33,39]. The here reported work used 
isolate F07-220, a subtype-1 isolate originated from an outbreak in Ireland. The virulence 
and pathogenicity of the isolate had been tested previously through in vivo challenges [32] 
and also used to test infectivity during the development and application of the SCPCs model 
[40,44]. 
 
Based on the interpretation of morphological features at the ultrastructural level of SPDV 
infected  SCPCs , our results generally align with those reported for other alphavirus species 
[36,42]. Features such as the  viral attachment to the cell surface is consistent with the 
reported binding to host cell receptors for alphavirus [51,52], as is the formation of early (EE) 
and late (LE) endosomes after internalization, or the presence of replication complexes 
involving membrane re-assemblage and formation of spherules,  all similar or equivalent to 
previously described features of alphavirus on vertebrate cell models [5]. There is also 
alignment with previous ultrastructural descriptions of SPDV in cell culture, such as vacuole 
associated spherules [39]. Interestingly, while several organs were examined in this 
aforementioned mentioned in vivo infection work, the authors reported that although features 
of replication could be seen in heart, kidney and gills, virus-like particles were observed only 
in the heart [33] but so far, no model system was available for examining virus-like particles 
and especially replication/ re-infection in vitro. 
 
Entry mechanisms  
 
For this early step of the virus life cycle, the current work builds on previous work reported 
for SPDV in vitro infection [39] by providing a thorough description of the process of viral 
attachment and internalization. This step had not been observed before. This may have 
been due to differences on host cells and tissues used, potential difference on isolates 
virulence or the effect of differences on experimental settings, e.g. double the adsorption 
time -2 h- in the current experiment. In this study, viral particles were observed during the 
process of internalization at 2 and 3 hpi, and again, at 24 hpi, simultaneously to the presence 




The initiation of infection was observed to occur through a close attachment of the virus with 
the cell, a contact that morphologically was observed as a mild electron dense cloudy region 
(Fig 1 A and B and insert). This type of attachment is very similar to that reported for SFV 
[53]. 
 
As intracellular parasites, viruses take advantage of the host cellular machinery for 
replication, requiring first to successfully deliver their genome into the cell. Most of the 
understanding of alphavirus entry has been obtained from studies focused on alphaviruses 
regarded as “Old World”, such as SINV and SFV. Comparably much less attention has been 
received by other species, although fundamental differences on the entry mechanisms have 
been suggested for other genus members such as VEEV [54].  
 
Conventionally, enveloped RNA viruses exhibit a two-step entry mechanism involving a 
receptor-mediated binding to host cell surface (likely represented in our study by the 
previously described attachment features), followed by a low pH-triggered membrane fusion 
of the viral and cell membranes that delivers the RNA into the cytoplasm [51,55]. These two 
steps may occur at the cell surface or after internalization of the virus by endocytosis or 
some other route. 
 
 Even for the reference prototypical alphaviruses, the precise mechanisms of internalization 
are still not totally clear [56]. Currently, CCP endocytosis is thought to be the most common 
route and this is consistently reported for SFV [51] and CHIKV [57]. However, endocytosis 
independent of CCP has been shown to occur in CHIKV [58] as well as in the absence of 
caveolar vesicles [59]. Even for the reference species SFV, the canonical CCP entrance may 
not necessarily be the only route. Early work using transmission electron micrographs 
showed that while the majority of the viral particles were internalised by the CCP 
endocytosis, a small number were observed and depicted using uncoated membrane 
invaginations [53]. Additionally, alternative paths, as distinct as virus genome injection 
directly through the cell plasma membrane, may occur in SINV virus [60,61]. Seemly, under 
non-permissive conditions for endocytosis or any vesicular transport, this mechanism allows 
entry of the viral genome by direct penetration of the plasma membranes through a pore 
formed by viral, and possibly host, proteins; a process suggested to be time- and 
temperature-dependent [62,63]. 
 
Morphologically, two types of entry features suggesting different mechanisms were apparent 
in SPDV infected SCPCs. One in line with the classic mechanism of clathrin dependent 
endocytic pathway (CCP), well-established and described for alphavirus [51], and another 
seemly clathrin independent (CI) mechanism using a caveolar or lipid raft-like structure. 
Pathways of clathrin-independent endocytosis for different molecules including viruses have 
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been previously reported, as well as specifically for Chikungunya, a  human  affecting 
alphavirus [58,64].  
 
The possibility that the feature described as CI mechanism may represent an artefact 
however, cannot be ruled out, as is based exclusively on the morphological observation of 
the absence of the characteristic clathrin spiky coat. It has been reported that once 
endocytosed, the clathrin coat on the virus-containing vesicles is rapidly removed and the 
virus delivered to the early endosome compartment [51]. 
 
In mammalian cells, the endocytic internalization of virus particles is possible though many 
different mechanisms, some on-going processes such as the CCP, and others ligand or 
cargo induced, such as the use of caveola [65]. Other mechanisms include macropinocytosis 
(adenoviruses), CI pathway from the PM (influenza and arenaviruses), caveolar pathway 
(one of the several cholesterol dependant used by SV40 or mouse polyoma) or a 
cholesterol-dependant endocytosis devoid of clathrin and caveolin-1 (used by polyomavirus 
and SV40) [65]. 
 
The clathrin-mediated pathway being the most commonly observed among viruses and the 
parallel observations in the infected SPCS of transport-like vesicles consistent with early and 
late endosomes and eventually lysosomes, would suggest the CCP mechanism is also the 
case for SPDV. 
 
However, it is not yet known for certain whether some pathogens requiring entrance to the 
host cell such as viruses follow pre-existing cell’s trafficking pathways or if they actually 
induce their own endocytic itinerary [64]. Important differences and variations are described 
for alphavirus in general, suggesting that there might not be a single model that can be used 
to compare or to fully describe the entry process in SPDV infection.  
 
The SCPCs model represents therefore a useful tool to examine in more detail this important 
aspect of the virus cycle. Further work could contribute to a better understanding of the entry 
mechanism and elucidate if artefacts are responsible for some of the current observations or 
if indeed, different mechanisms could potentially occur simultaneously or under different 
conditions. The model can also be used to explore the hypothetical re-infection process 
suggested by the re-internalization features observed after 24 hpi. 
 
Full understanding of the entry mechanisms of SPDV would not only be relevant for the 
elucidation of steps of the viral replication cycle, but could also play an important role for the 
potential development of rational antiviral therapies, for example exploiting compounds 




Post internalization events 
 
Following internalization, abundant trafficking vesicles were observed consistent with 
cytoplasmic translocation of virus particles. Newly internalised virus containing vesicles could 
be seen fused with endocytic vacuoles to form early endosomes (EE), with almost intact viral 
particles within. Free cytoplasmic virus-like particles were also observed. Late endosomes 
are larger vacuolar structures containing a mix of degenerating material (residual bodies) 
simultaneously with still visible viral particles. Both EE and LE were seen in samples at 2 and 
3 hpi. For  alphavirus , a low pH mediated process in the LE has been described to be 
necessary to allow the fusion of the viral and the endosome membranes to release the 
nucleocapsid core (NC) into the cytoplasm, where it will be disassembled [42].  
 
In general, positive-strand RNA viruses replicate their genomes in association with 
remodelled, intracellular, membrane arrangements such as single or double-membrane 
vesicles. However, even in very thoroughly studied viruses the exact sites of RNA synthesis, 
the mechanisms involved or the topological relationships between membranes vesicle 
content and cytoplasm, are frequently poorly defined [66].  
 
Consistent though with description for other alphavirus in mammalian and insect cell models, 
SPDV infection showed to induce the re-arrangement and remodelling of cell membranes. 
The alphavirus RNA is known to replicate and transcribe in “replication complexes” (RC) 
formed soon after infection on endosomal and lysosomal membranes by host and viral RNA 
proteins [5,67]. The replication and transcription induce the formation of spherules, 
visualised as multiple endocytic processes resembling caveolae and multi-caveolar-like 
vesicles. These structures are derived from host cell membranes, with PM, mitochondria and 
ER being frequently hijacked for that purpose by positive-strand RNA viruses [68]. The 
spherules can be re-localised by trafficking through the cytoplasm to the peri-nuclear region. 
A cytopathic vacuole type I (CPV-I) is formed as the replication spherules are internalized 
and the vesicles are fused with lysosomes.  
 
The size of spherules has been reported to be closely connected to the length of the 
replicating RNA template [69]. The SCPCs infected with SPDV showed spherule-like 
structures forming at membrane surfaces and within vacuoles in the peri-nuclear region, with 
a size range of 35-55 nm. This is consistent with  spherule formation of ~50 nm reported in 
SINV infection [42] and in SFV, where a viral-genome template of 11.5 kb induced spherules 
of ∼58 nm diameter, and a template of 6 kb yielded ∼39 nm spherules; the two size classes 
in the same cell [69]. In the current work a connecting tube or neck-like structure was 
observed in some spherules containing vacuoles, suggestive of trafficking of spherules into 
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the vacuoles located at the peri-nuclear region. Additionally, spherules themselves showed a 
connection similar to a neck opening into the cytoplasm. The latter has been reported to 
allow export of progeny RNA destined for translation or packaging and import of metabolites 
required for replication [70]. 
 
Naturally, many of the viral synthesis events that use the host cell machinery cannot be 
demonstrated or confirmed by ultrastructural examination. These  include the RNA synthesis 
reported to occur with the non-structural proteins (nsP) accumulating at the cytoplasmic neck 
of the spherules, followed by newly synthesized RNA diffusing into the cytoplasm [42,67]. 
The structural capsid proteins (CP) are translated from the sub-genomic RNA and this 
polyprotein is then autocatalytically processed, resulting in the release of CP into the 
cytoplasm. The cellular secretory pathway plays an important role in the virus replication and 
assembly by transporting CPV-I and CPV-II to the PM, as demonstrated with SINV by live 
imaging experiments [42]. It was also shown that CPV-II originates from the trans-Golgi 
network ~4  hpi in mammalian cell lines. CPs in the cytoplasm encapsidate single genomic 
RNA to form the nucleocapsid core (NC), which will then bind to the glycoprotein spikes, 
already located at PM forming the envelope during virus budding [42].  
 
Unequivocal CPV-II structures have not been observed in the current SCPCs infection. 
However, structures interpreted as hypothetically “functionally equivalent”, where observed 
and described. They are in line with the most recent description for the type of structure in a 
SINV infected vertebrate cell line [42]. A mild or dense appearance of the inner or core 
centre of the vacuoles is interpreted as possibly cross sections at different planes as has 
been described for CPV-II from another alphavirus in vitro (SFV infections on BHK-21 cells) 
[71]. CPV-II structures in SPDV in vitro infection had been reported [39], however different to 
the here described. 
 
Viral assembly and budding 
 
Alphavirus in vertebrate host and mammalian cell lines have been shown to assemble by 
budding at the PM of the infected cell when the ensemble NC core acquires a host derived 
envelope of phospholipid membrane, and an outer glycoprotein layer [72]. In our study 
particles budding from cell PM were observed at 48 hpi. Electron dense segments of PM 
were observed at or close to points of budding, which can be interpreted as the display of 
such envelope proteins. The rationale for this is based in electron tomography studies on 
SFV, where it was shown that the envelope E1/E2 glycoproteins are arranged in the CPV-II 
and introduced at the PM budding sites as a lattice, resembling already their organization on 
the viral envelope [71]. Interestingly, we noted cytoplasmic small vesicle structures of a 
similar size to complete virions but with an empty core bearing an external spiky surface 
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resembling those on the viral envelope. In previous SPDV morphogenesis in vitro work [39], 
a Golgi apparatus and vacuoles characterized by ‘fuzzy’-coated membranes were 
incidentally reported as more frequent in the infected cells. In addition, with the current 
observations and the evidence for SFV, a potential interpretation of such structures may be 
that these vesicles represent envelope proteins before translocation to the PM through the 




While the focus of the current work was describing features believe to correspond to events 
of the SPDV replication cycle, other observations which were consider relevant were also 
noted and described. For example, the presence of clustered granular structures consistent 
with stress granules (SG), which to the best of the authors’ knowledge, have not previously 
been reported for SPDV. 
 
Development of SG in mammalian cells is not a rare event, as translational attenuation is 
known to result in the formation of stress granules which contain ribonucleoproteins 
(mRNPs) and stalled translation initiation complexes. The packaging of cytoplasmic mRNA 
into discrete RNA granules regulates the gene expression, by delaying the translation of 
specific transcripts [43]. SG appear to be associated with stress events that severely repress 
translation, such as heat shock, oxidative stress or UV radiation [73]. Additionally, viral 
infection causes stress at multiple levels which can also reduce host translation, and through 
a complex series of events, lead to the formation of stress granules [74]. Arboviruses such 
as the majority of alphavirus, moreover, have been speculated to be capable to modulate the 
SG response in invertebrate hosts, decreasing but not completely repressing the effects of 
antiviral pathways. This balances the levels of viral replication and the fitness of the vector 
host [75]. In SFV, SG has been reported to occur transiently and later disassemble with the 
ongoing viral replication. Many viruses can effectively counteract the assembly of SGs, 
suggesting their involvement in antiviral activity [76].  
Another observed feature that represent an event not described for SPDV and differing from 
alphavirus in other vertebrate hosts, are the filopodial projections seen at the PM in 
endothelial cells and leukocytes. Similarly, the membrane bounded cytoplasmic vacuoles 
morphological consistent with internal budding (see Fig 5 and 6). Interestingly, the SCPCs 
model benefits from the presence of endothelial cells [40], a cell type which has recently 
been highlighted on its importance for the early events of Chikungunya infections [77] 
Filopodial projections and the putative internal budding observed here  have only recently 
been described associated with alphavirus in their invertebrate hosts (mosquito cell lines) 
[42]. Filopodial extensions associated with viral dissemination were shown to develop in a 
mosquito cell line (C6/36, originally known as the ATC-15) [78] and where the viral 
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glycoproteins and the virus budding also occurred both at the PM as well as into internal 
vesicles. Recent work lead to the hypothesis that, in the mosquito cell line model, alphavirus 
shows a characteristic that favours a transition towards persistent infections, and which 





The observations gathered in our study of SPDV infected SCPCs, while in line with previous 
studies, also indicate the potential simultaneous occurrence of events described for 
mammalian alphaviruses infecting vertebrate and invertebrate cell lines. It is noteworthy that 
in mammalian cell lines alphavirus frequently results in acute infections and cytolysis, while 
in insect cell lines, the host cells survive infections and may later spread the disease through 
a biological process known as RNA interference (RNAi), a major antiviral pathway that 
modulates arbovirus infections by a gene silencing conserved mechanism [79–81]. This may 
be related to the capacity to establish persistent infection with no cytopathic effects [42,82].  
Based on the current study, it may be suggested that SPDV may have the capacity to 
establish both cytolytic and non-cytolytic persistent infections in the same host. In this 
hypothetical scenario, the capacity to alternate between cytolytic and non-cytolytic persistent 
infections could relate to the clinical presentation of the disease. Mortality on SPDV infection 
is the outcome for a variable proportion of infected fish, whereas the condition persists 
without killing the majority of the host population. Also, clinical recurrence has been reported 
regardless of rest periods between introductions of new generations into vacant enclosures. 
Both of these observations may be suggestive of viral persistence in the host in the absence 
of clinical disease. Longitudinal studies in Scotland [83] and to a lesser extent in Norway, 
have reported fish from sites never diagnosed with PD that were found to be SPDV-positive 
at slaughter [84].  
 
On one side, non-lethal SPDV infection of at least one non-salmonid species (common dab 
Limanda limanda) has been reported as a wild reservoir which presented no clinical signs or 
characteristic PD histopathological lesions [16–18]. On the other side, the members of 
Alphaviridae have been suggested to have originated in the aquatic environment [2], 
acquiring the ability to infect warm-blooded vertebrates and mosquito vectors secondarily,  a 
characteristic  described as a safeguard of the maintenance of the agent in the environment. 
Additionally, it has been hypothesized that arboviruses are more constrained than single-
host RNA viruses in adaptability [85] by alternating transmission between vertebrate and 
invertebrate hosts. Together these would support a hypothesis that SPDV, as an aquatic and 
older alphavirus, may have retained a capacity to establish cytopathic as well as persistent 
infections in the same host before the group became terrestrial arbovirus. This could at least 
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partially explain the observations in Atlantic salmon aquaculture and the non-pathological 
infections noted in reservoir species in the marine environment.  
 
Recent studies have pointed to fundamental mechanistic differences between insect and 
mammalian cell lines in the interaction of alphavirus replication and structural components, 
showing how viruses can exploit the resources and environment of their specific hosts [42]. 
Additionally, the involvement and potential role of host RNA-binding protein interactions 
during viral replication has been also explored [86]. This interaction with cell-type-specific 
factors is now recognised as an area requiring further research, to improve understanding of 
both the regulation of viral replication and gene expression and of virus species-specific 
pathogenesis [82]. The use of a species-specific model as in the present work, containing 
different cell types from a fish organ known to be affected by the virus, might prove of further 
practicality as it would support exploration of potential cell-type-specific factors in SPDV 
infections. 
 
In conclusion, SPDV has been affecting the salmon farming industry for over 30 years but in 
spite the substantial amount of studies along these years, there are still a number of 
recognised knowledge gaps requiring further research, among them the transmission of the 
virus [25,87]. Tt will only be through a deeper and more thorough understanding of the 
mechanisms used by SPDV and its pathogenesis that effective targeted therapeutics can be 
developed. The current study provides information extracted from an in vitro model system 
which has given new insights into several aspects of the viral replication cycle, bringing 
hypothesis and opening new research avenues such as a putative capacity for non-cytolytic 






Fig 1: Transmission electron micrograph of Salmon cardiac primary cultures infected with SPDV 
subtype-1 at 2.4 x 104 plaque forming units (PFU)/ml and fixed for analysis at 2-3 hpi. Features of the 
viral entry. (A) viral particles at sequential steps of the entry process. Note contact established through 
an electron dense cloud (arrows) between the virion and the cell surface (top particle and insert) and 
initiation of internalization of a second virion below, already within the invaginating plasma membrane. 
(B) Extracellular virion attached to cell surface and formation of concavities at the plasma membrane 
adjacent or just below the point of contact (arrow heads). (C) Detail of a clathrin coated pit (CCP) at the 
cell membrane (arrow head) and seemingly remnants of a CCP membrane fragment (arrow) in the 
cytoplasm, likely post particle release. (D) Detail of CCP formation with an almost fully close and 
another CCP developing on the opposite adjacent cell. Note increased electron dense section of 
plasma membrane (white arrow) in the proximity of CCP. A possible internalised virion is observed 
within a fainting vacuolar structure (black arrowhead). (E) A cell where CCP-dependent (black 
arrowheads) are clearly observed while an internalised viral-like particle within a non-spiky-coated 
vesicle (white arrowhead) is seen simultaneously within the same cell. (F) Intact virion free in the 
cytoplasm above mitochondria (M). Insert shows a particle releasing from vesicle membrane still 






Fig 2: Transmission electron micrograph of Salmon cardiac primary cultures infected with SPDV 
subtype-1 at 2.4 x 104 plaque forming units (PFU)/ml and fixed for TEM analysis at 2 -3 hpi. Features 
of cytoplasmic events post viral internalization. (A) Recently internalized viral particles within early 
endosome (EE). An early endosome (EE) shows particles still partially linked to vesicles membrane 
(white arrow) and several free particles in the cytoplasm (arrow heads). Note active endoplasmic 
reticulum (RE). (B) Connection established between single particle pit coated vesicle and a larger 
endosome-like compartments, through a tubular /neck structure (arrow head). Note multiple intact virus 
particles (arrow) within the endosome (arrow). (C) Larger endosomal structure containing multiple 
vesicles (white arrow) with some viral particles yet being released from EE (insert enlargement). Note 
electron-dense layer lining endosome membranes. (D) Large vesicle consistent with LE containing 
numerous packed viral particles (arrow) mixed with debris. Note myofiber (My) and active ER. Bars: A, 





Fig 3: Transmission electron micrograph of Salmon cardiac primary cultures infected with SPDV 
subtype-1 at 2.4 x 104 plaque forming units (PFU)/ml and fixed for TEM analysis at 3 hpi. Features of 
membrane remodelling and formation of spherules and cytopathic vacuoles type I (CPV-I). (A) 
Spherules observed in the nearby of plasma membrane within a loose vacuolar structure. Note the 
connection between single spherule with membrane by a neck structure (arrowhead). (B) Higher 
magnification of spherules formation. (C) Spherules contained within a cytoplasmic vacuole nearby the 
nucleus (N). Note prominent tubular connecting structure (white arrow) also containing spherules. (D) a 
close up of a similar structure as shown in C, note spherule close contact with vacuoles membranes 
(arrowheads) and a high electron dense region of the later (arrow). (E) Spherules containing vacuoles 
morphologically consistent with cytopathic vacuoles type I (CPV-I) located in the perinuclear region 
(arrow) and in the proximity of the rough endoplasmic reticulum (RER). (F) CPV-I containing single 





Fig 4: Transmission electron micrograph of Salmon cardiac primary cultures infected with SPDV 
subtype-1 at 2.4 x 104 plaque forming units (PFU)/ml and fixed for TEM analysis at >24 hpi. Features of 
cytoplasmic vacuoles type II (CPV-II) putative structures. (A) Numerous pleomorphic, round to ovoid 
CPV-II like complexes, clustered near the cell membrane. Note those with a mild electron dense centre 
and visible defined darker periphery (arrow), and those that appear as a dark, high electron dense 
vacuole (arrowheads). (B) As in A, at higher magnification both mild and high electron dense vacuoles 
are interpreted as sections at different levels of identical structures. Both present evenly distributed, 
~25-30 nm nucleocapsid like particles arranged on their surface. Bars: A = 500 nm, B = 200 nm. 
 
 
Fig 5: Transmission electron micrograph of Salmon cardiac primary cultures infected with SPDV 
subtype-1 at 2.4 x 104 plaque forming units (PFU)/ml and fixed for TEM analysis at 24 and >48 hpi. 
Features of extra and intra cytoplasmic budding. (A) Budding at plasma membrane (arrow). Note 
broken continuity of plasma membrane due small missing portions (arrowheads). (B) Budding particle 
where nucleocapsid core can be seen within as cell membrane envelope is being formed (arrow). (C) A 
cytoplasmic vacuolar structure containing viral like particles (arrowhead), hypothesised as a feature of 
putative intra cytoplasmic budding. Arrow indicates a distinctly darker section of plasma membrane 
resembling accumulation of envelope glycoproteins in preparation of the budding process. (D) A 
cytoplasm vacuole contained a viral particle. Note vacuole interrupted membrane and the tubular 





Fig 6: Transmission electron micrograph of Salmon cardiac primary cultures infected with SPDV 
subtype-1 at 2.4 x 104 plaque forming units (PFU)/ml. Additional observations at > 24 hpi. (A) Putative 
re-infection process. Attaching virion at plasma membrane (arrow), and a virion internalized by clathrin-
mediated endocytosis (CCP) (arrow head). Note sub-membranous electron dense band. (B) Putative 
re-infection process by formation of caveolar type invaginations at cell surface (arrowheads) and virion 
internalization by a CCP-independent process (arrow). (C and D) Intra cytoplasmic clusters of loosely 
organised electron dense particles into aggregates consistent with ribonucleoprotein stress granules 
(SG). Note clear areas of fibrillar patches within the SG and presence in the surrounding area of viral 
like particles displaying a regular spiky surface (arrowheads). (E) A scaffold of filopodial extensions 
between two neighbouring cells. (F) Filopodial extension in an endothelial cell lining SCPCs internal 
chamber, and extending form intraluminal leukocyte. Insert shows branching filopodial extension with 
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Infections by Salmon Pancreas Disease Virus (SPDV), primarily in Atlantic salmon (Salmo 
salar L.) but also rainbow trout (Oncorhynchus mykiss), have been affecting the farmed 
salmonids industry in the UK, Ireland, Norway and continental Europe for over 30 years. 
 
This thesis was framed within a project in accordance with governmental aquaculture 
policies at Marine Scotland Science (MSS), the Scottish National Reference Laboratory. At 
the heart of it was to address some of the SPDV knowledge gaps identified by the industry 
and the research communities. The general aim therefore was to improve and develop new 
approaches on experimental models, especially applicable to the study of SPDV in Atlantic 
salmon. The work was approached through in vivo and in vitro studies.  
 
For the first part, the in vivo work aimed to move from the traditional intra peritoneal (ip) 
infections of salmon par in fresh water, to the implementation of sea water co-habitation 
challenges with salmon post smolts.  
 
Through evaluation and selection among SPDV isolates of different subtypes, chapter 1 
provided information on suitable isolates based on their intraperitoneal infectiveness at 
several tissue levels. Two isolates, namely 4640 and F07-220 were identified and results 
also provide information on virus tissue tropism, which later allowed narrowing the number of 
analysed tissues during the viral load assessment during co habitation.  
 
A second part of the in vivo section used selected isolate 4640 along the subtype 1 
reference F93-125 to successfully establish a viral infection in sea water by transmission 
through co habitation using Atlantic salmon post smolts (chapter 2). This experimental 
approach represents a more natural transmission route within the environment and with fish 
at the developmental stage predominantly affected by the disease. The experimental setting 
has since been used at MSS for subsequent disease studies, fulfilling the objectives of in 
vivo work established for this thesis. 
 
Selected isolate F07-220 was the main one used for the experiments of the in vitro sections 
of this thesis. (Chapters 3-5)   similarly aimed to bring an alternative approach and introduce 
a higher level of complexity to laboratory-based studies. The development, optimization and 
application of an ex vivo cardiac primary culture (SCPCs) originated from Atlantic salmon 
embryos, was set as a goal in order to study cardiotropic agents in Atlantic salmon (Chapter 
147 
 
3). The choice of the heart as target tissue for this section was partially based on the 
observations during the in vivo work where tissue tropism studies pointed to the relevance of 
the heart during SPDV infections. It was also influenced by the awareness that heart is one 
of the organs that describes major histopathological changes during the course of SPDV 
infections. Additionally, it was becoming very evident that besides SPDV, other viral agents 
such as Piscine Reovirus (PRV) and Piscine Myocarditis Virus (PMCV), responsible for the 
conditions known as heart and skeletal muscle inflammation (HSMI) and cardiomyopathy 
syndrome (CMS) respectively, also affected the salmon heart and were becoming 
increasingly a concern for the industry.  
 
The results obtained for the in vitro section, the SCPCs, accounted for the more innovative 
part of this thesis. A relative lengthy process was required at start to refine the SCPCs 
production and achieve efficiency at synchronously obtaining sufficient numbers of cultures 
to allow for experimentation including longitudinal trials. During this process tools that could 
be applied, particularly related to SCPCs very small size, were explored and tested, 
including molecular approaches (RT-PCR), histology, histochemistry and electron 
microscopy. SCPCs could be kept viable under laboratory conditions with minimal 
maintenance for periods up to 6 months. The model was successfully challenged with 
different SPDV isolates and other cardiotropic viral agent (e.g. Infectious Salmon Anaemia, 
ISA,) to prove the model permissiveness to infection. The results showed the kinetics of viral 
infection and a relevant element of the immune response (i.e. expression of mx gene) could 
be studied along time (Chapter 3, paper 1).  
 
Another explored application of the model was to compare the viral load and mx kinetics 
after SPDV challenge between SCPCs of different genetic backgrounds (i.e. IPNV resistant 
vs. IPNV sensitive). Results showed measurable differences between the groups after 
infection, highlighting the potential use of SCPCs to examine genotype-based differences in 
response to viral disease (Chapter 4, paper 2).  
 
A further and last application of the SCPCs model within this project was to study the SPDV 
replication cycle using transmission electron microscopy (TEM) (Chapter 5). Profound a 
comprehensive information on virus replication cycle and its interactions with the host will 
always be a requisite in order to develop control strategies. This part of the work resulted in 
novel insights on the replication cycle of SPDV, drawing from the extensive literature in 
mammalian alphavirus work. Observed features included some not previously reported for 
SPFD, such as presence of filopodial extensions and “stress granule” like structures and 
particularly, putative intracytoplasmic budding capacity that underpins a suggested 
hypothesis that SPDV may be able to establish both cytolytic and non-cytolytic infections in 




SPDV and other virus associated cardiomyopathies remain a serious issue affecting the 
Atlantic salmon aquaculture industry. Further work on this and other cardiotropic agents will 
still be required to help support the development of disease control and management 
strategies, including host genetic increased resistance and /or vaccine development.  
 
The SCPCs model generated during this thesis has the potential to contribute on its present 
form, in aspects such as examining intra organ cell tropism or assess relevant replication 
cycle events such as the initial viral fusion, relevant to the understanding of potential 
inhibitors and extremely promising for both research and therapeutic uses. For other uses 
such as the host genotypic screening, further characterisation would be required to establish 
the model as a robust platform, including increasing experimental sample size, testing the 
use of single (individual) versus multiple (pooling) SCPCs, or exploring the potential of non-
destructive approaches by using sequential culture supernatant collection. The “gold 
standard” required to verify the results would be provided by the comparison of results in 
vitro obtained with SCPCs of a given origin, with those further on time from in vivo 
challenges results, using fish originated in the same stock and using a combination of 





For chapter 1  
 
All isolates added to TO cells and incubated at 15°C. Samples were taken at days 1, 2, 3, 4, 
6, 7, 10, 12 and 14 after inoculation (x3 infected and un-infected controls wells). RNA was 
extracted from the infected cell cultures using the RNA/DNA/Protein purification Kit (Qiagen) 
according to manufacturer’s instructions and reverse transcribed to cDNA using the 
TaqMan® Reverse Transcription Reagent kit (ABI) with random hexamers. Real-time PCR 
assays were performed on an ABI 7000 Sequence Detection System (Applied Biosystems). 




Figure 1: Kinetics of expression of nsP1 in TO cells infected with different SPDV isolates. Viral RNA 
expressed as relative to reference housekeeping gene (elf). Data represent mean values ± SE (N = 3). 
Note a group of higher responders including isolates 4640, 4639 and 4638. Peak expression of isolate 




Source: MSS internal reports (Collet B.  2010: Comparative analysis of five Salmon 

















































Attendance and presentation of work related to this thesis along the 
period of study: 
 
  
-15th International conference on Diseases of Fish and Shellfish of the European Association 
of Fish Pathologists (EAFP) Split, Croatia 2011 (poster) on initial development of SCPCs. 
 
-Tri Nation PD meeting 2012 (oral presentation) Characterization of the model.  
 
-16th International conference on Diseases of Fish and Shellfish of the European Association 
of Fish Pathologists (EAFP) Tampere , Finland 2013 (oral paper) permissiveness of infection 
of SCPCs. 
 
- 9th International Conference on Viruses of Lower Vertebrates, Malaga, Spain  2014 (oral 
paper) application as in medium term trial, viral and mx gene expression. Selected as one of 
the 12 best scientific presentations. 
 
-University of Edinburgh Student day 2015 (poster), Runner up price. 
 
- 18th International conference on Diseases of Fish and Shellfish of the European 
Association of Fish Pathologists (EAFP) Belfast, Dublin 2017 (oral paper) use of the model 
for embryo genotype assessment.  




A) A method to measure an indicator of viraemia in Atlantic salmon using a reporter cell line, 
Bertrand Collet, Katy Urquhart, Patricia Noguera, Katrine H. Larsen, Katherine Lester, David 
Smail, David Bruno. 
 
B) Identification of a wild reservoir of Salmonid alphavirus in common dab Limanda limanda, 
with emphasis on virus culture and sequencing, D. W. Bruno, P. A. Noguera, J. Black, W. 
Murray, D. J. Macqueen, I. Matejusova. 
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